| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.694 | 0.003 | 0.745 | Anesthetic local | 0.745 0.003 DBMET02254 0.672 0.003 DBMET02256 0.72 0.003 DBMET02242 0.292 0.013 DBMET02245 0.335 0.01 DBMET02244 0.335 0.01 DBMET02247 0.296 0.013 DBMET02248 0.601 0.004 DBMET02249 0.276 0.015 DBMET02250 0.633 0.003 DBMET02252 0.356 0.009 DBMET02255 0.227 0.025 DBMET02251 | DBMET02254 | |
| 0.593 | 0.008 | 0.781 | Vasodilator, coronary | 0.524 0.013 DBMET02254 0.593 0.008 DBMET02256 0.569 0.009 DBMET02242 0.669 0.005 DBMET02245 0.326 0.069 DBMET02244 0.326 0.069 DBMET02247 0.31 0.079 DBMET02248 0.518 0.013 DBMET02249 0.781 0.004 DBMET02250 0.569 0.009 DBMET02252 0.289 0.097 DBMET02255 0.264 0.12 DBMET02251 | DBMET02250 | |
| 0.599 | 0.016 | 0.733 | Vasodilator, peripheral | 0.51 0.026 DBMET02254 0.581 0.018 DBMET02256 0.598 0.016 DBMET02242 0.732 0.005 DBMET02245 0.264 0.117 DBMET02244 0.264 0.117 DBMET02247 0.194 0.183 DBMET02248 0.502 0.027 DBMET02249 0.733 0.005 DBMET02250 0.597 0.016 DBMET02252 0.223 0.15 DBMET02255 0.272 0.112 DBMET02251 | DBMET02250 | |
| 0.571 | 0.009 | 0.636 | Calcium channel L-type activator | 0.557 0.012 DBMET02254 0.57 0.009 DBMET02256 0.574 0.009 DBMET02242 0.305 0.153 DBMET02245 0.636 0.004 DBMET02244 0.636 0.004 DBMET02247 0.602 0.005 DBMET02248 0.594 0.006 DBMET02249 0.576 0.009 DBMET02252 0.61 0.005 DBMET02255 0.6 0.006 DBMET02251 | DBMET02247 | |
| 0.558 | 0.005 | 0.67 | P-glycoprotein inhibitor | 0.536 0.006 DBMET02254 0.54 0.006 DBMET02256 0.54 0.006 DBMET02242 0.632 0.004 DBMET02245 0.44 0.012 DBMET02249 0.67 0.004 DBMET02250 0.51 0.008 DBMET02252 | DBMET02250 | |
| 0.505 | 0.015 | 0.589 | Cardiotonic | 0.482 0.017 DBMET02254 0.453 0.02 DBMET02256 0.504 0.015 DBMET02242 0.506 0.015 DBMET02245 0.173 0.147 DBMET02244 0.173 0.147 DBMET02247 0.411 0.027 DBMET02249 0.589 0.008 DBMET02250 0.439 0.022 DBMET02252 0.173 0.147 DBMET02255 0.225 0.099 DBMET02251 | DBMET02250 | |
| 0.467 | 0.044 | 0.704 | 5 Hydroxytryptamine release inhibitor | 0.384 0.089 DBMET02254 0.468 0.044 DBMET02256 0.439 0.057 DBMET02242 0.704 0.004 DBMET02245 0.369 0.099 DBMET02244 0.369 0.099 DBMET02247 0.537 0.022 DBMET02248 0.48 0.039 DBMET02249 0.512 0.029 DBMET02250 0.328 0.136 DBMET02252 0.316 0.147 DBMET02255 0.526 0.025 DBMET02251 | DBMET02245 | |
| 0.436 | 0.014 | 0.494 | Calcium channel activator | 0.404 0.023 DBMET02254 0.415 0.02 DBMET02256 0.371 0.037 DBMET02242 0.393 0.027 DBMET02245 0.494 0.005 DBMET02244 0.494 0.005 DBMET02247 0.339 0.057 DBMET02248 0.352 0.049 DBMET02249 0.384 0.031 DBMET02250 0.396 0.026 DBMET02252 0.466 0.008 DBMET02255 0.358 0.044 DBMET02251 | DBMET02247 | |
| 0.492 | 0.076 | 0.492 | Beta lactamase inhibitor | 0.345 0.117 DBMET02254 0.383 0.105 DBMET02256 0.348 0.116 DBMET02242 0.408 0.097 DBMET02244 0.408 0.097 DBMET02247 0.328 0.123 DBMET02248 0.321 0.126 DBMET02249 0.296 0.136 DBMET02252 0.233 0.165 DBMET02255 0.249 0.157 DBMET02251 | ||
| 0.407 | 0.004 | 0.44 | Nav1.1 sodium channel blocker | 0.366 0.005 DBMET02254 0.385 0.005 DBMET02256 0.409 0.004 DBMET02242 0.232 0.014 DBMET02245 0.159 0.03 DBMET02244 0.159 0.03 DBMET02247 0.126 0.044 DBMET02248 0.396 0.005 DBMET02249 0.44 0.004 DBMET02250 0.366 0.005 DBMET02252 0.111 0.055 DBMET02255 | DBMET02250 | |
| 0.438 | 0.043 | 0.487 | Thyroid hormone beta antagonist | 0.43 0.045 DBMET02254 0.433 0.044 DBMET02256 0.435 0.044 DBMET02242 0.344 0.071 DBMET02244 0.344 0.071 DBMET02247 0.346 0.07 DBMET02248 0.325 0.077 DBMET02249 0.182 0.171 DBMET02250 0.258 0.114 DBMET02252 0.34 0.072 DBMET02255 0.487 0.034 DBMET02251 | DBMET02251 | |
| 0.434 | 0.047 | 0.52 | Thyroid hormone antagonist | 0.429 0.048 DBMET02254 0.434 0.047 DBMET02256 0.441 0.045 DBMET02242 0.351 0.073 DBMET02244 0.351 0.073 DBMET02247 0.365 0.068 DBMET02248 0.329 0.081 DBMET02249 0.186 0.174 DBMET02250 0.254 0.121 DBMET02252 0.359 0.07 DBMET02255 0.52 0.029 DBMET02251 | DBMET02251 | |
| 0.383 | 0.005 | 0.383 | Nav1.3 sodium channel blocker | 0.231 0.017 DBMET02254 0.289 0.01 DBMET02256 0.304 0.009 DBMET02242 0.193 0.027 DBMET02245 0.175 0.034 DBMET02244 0.175 0.034 DBMET02247 0.145 0.051 DBMET02248 0.362 0.005 DBMET02249 0.234 0.016 DBMET02250 0.377 0.005 DBMET02252 | ||
| 0.465 | 0.091 | 0.599 | Alpha-glucosidase inhibitor | 0.476 0.087 DBMET02254 0.599 0.054 DBMET02256 0.553 0.065 DBMET02242 0.344 0.138 DBMET02245 0.287 0.167 DBMET02244 0.287 0.167 DBMET02247 0.327 0.147 DBMET02248 0.419 0.106 DBMET02249 0.517 0.076 DBMET02252 0.329 0.146 DBMET02255 | DBMET02256 | |
| 0.409 | 0.038 | 0.618 | Spasmolytic | 0.452 0.03 DBMET02254 0.455 0.03 DBMET02256 0.462 0.029 DBMET02242 0.581 0.015 DBMET02245 0.17 0.145 DBMET02244 0.17 0.145 DBMET02247 0.181 0.136 DBMET02248 0.361 0.049 DBMET02249 0.618 0.011 DBMET02250 0.348 0.053 DBMET02252 0.2 0.12 DBMET02255 0.167 0.148 DBMET02251 | DBMET02250 | |
| 0.374 | 0.008 | 0.374 | Nav1.2 sodium channel blocker | 0.247 0.022 DBMET02254 0.307 0.014 DBMET02256 0.328 0.012 DBMET02242 0.192 0.037 DBMET02245 0.201 0.034 DBMET02244 0.201 0.034 DBMET02247 0.157 0.053 DBMET02248 0.347 0.01 DBMET02249 0.218 0.029 DBMET02250 0.273 0.018 DBMET02252 0.108 0.098 DBMET02255 | ||
| 0.45 | 0.097 | 0.5 | DNA directed DNA polymerase inhibitor | 0.474 0.09 DBMET02254 0.476 0.09 DBMET02256 0.5 0.082 DBMET02242 0.377 0.126 DBMET02244 0.377 0.126 DBMET02247 0.451 0.097 DBMET02248 0.45 0.097 DBMET02249 0.332 0.147 DBMET02252 0.407 0.113 DBMET02255 0.301 0.161 DBMET02251 | DBMET02242 | |
| 0.415 | 0.068 | 0.711 | Histamine release inhibitor | 0.37 0.091 DBMET02254 0.439 0.056 DBMET02256 0.476 0.038 DBMET02242 0.711 0.004 DBMET02245 0.236 0.166 DBMET02244 0.236 0.166 DBMET02247 0.456 0.047 DBMET02248 0.423 0.064 DBMET02249 0.5 0.029 DBMET02250 0.283 0.133 DBMET02252 0.234 0.168 DBMET02255 0.509 0.026 DBMET02251 | DBMET02245 | |
| 0.342 | 0.014 | 0.342 | Cytidine deaminase inhibitor | 0.264 0.026 DBMET02254 0.277 0.023 DBMET02256 0.316 0.017 DBMET02242 0.174 0.06 DBMET02245 0.259 0.027 DBMET02244 0.259 0.027 DBMET02247 0.168 0.063 DBMET02248 0.294 0.02 DBMET02249 0.247 0.03 DBMET02250 0.29 0.021 DBMET02252 0.171 0.061 DBMET02255 | ||
| 0.327 | 0.004 | 0.327 | Calcium antagonist | 0.235 0.01 DBMET02254 0.235 0.01 DBMET02256 0.219 0.011 DBMET02242 0.316 0.004 DBMET02245 0.186 0.015 DBMET02244 0.186 0.015 DBMET02247 0.085 0.06 DBMET02248 0.252 0.008 DBMET02249 0.284 0.005 DBMET02250 0.267 0.007 DBMET02252 0.082 0.062 DBMET02255 | ||
| 0.337 | 0.016 | 0.506 | DNA methyltransferase I inhibitor | 0.319 0.02 DBMET02254 0.37 0.012 DBMET02256 0.337 0.016 DBMET02242 0.4 0.009 DBMET02245 0.174 0.084 DBMET02244 0.174 0.084 DBMET02247 0.241 0.051 DBMET02249 0.506 0.005 DBMET02250 0.327 0.018 DBMET02252 0.176 0.082 DBMET02255 0.217 0.061 DBMET02251 | DBMET02250 | |
| 0.368 | 0.052 | 0.867 | Aldehyde oxidase inhibitor | 0.29 0.069 DBMET02254 0.532 0.028 DBMET02256 0.462 0.038 DBMET02242 0.867 0.004 DBMET02245 0.147 0.142 DBMET02244 0.147 0.142 DBMET02247 0.401 0.047 DBMET02248 0.347 0.056 DBMET02249 0.748 0.005 DBMET02250 0.152 0.137 DBMET02252 0.164 0.127 DBMET02255 0.317 0.062 DBMET02251 | DBMET02245 | |
| 0.329 | 0.026 | 0.334 | ErbB-1 antagonist | 0.298 0.034 DBMET02254 0.314 0.029 DBMET02256 0.303 0.032 DBMET02242 0.275 0.041 DBMET02245 0.23 0.064 DBMET02249 0.334 0.025 DBMET02250 0.283 0.038 DBMET02252 | DBMET02250 | |
| 0.309 | 0.027 | 0.414 | Gastrin inhibitor | 0.257 0.071 DBMET02254 0.261 0.067 DBMET02256 0.293 0.038 DBMET02242 0.315 0.024 DBMET02245 0.322 0.02 DBMET02244 0.322 0.02 DBMET02247 0.372 0.007 DBMET02248 0.319 0.021 DBMET02249 0.278 0.05 DBMET02250 0.26 0.068 DBMET02252 0.263 0.065 DBMET02255 0.414 0.004 DBMET02251 | DBMET02251 | |
| 0.397 | 0.12 | 0.426 | DNA polymerase beta inhibitor | 0.341 0.144 DBMET02254 0.417 0.112 DBMET02256 0.426 0.109 DBMET02242 0.379 0.128 DBMET02244 0.379 0.128 DBMET02247 0.313 0.158 DBMET02248 0.267 0.182 DBMET02249 0.221 0.21 DBMET02252 0.326 0.151 DBMET02255 0.302 0.165 DBMET02251 | DBMET02242 | |
| 0.303 | 0.027 | 0.472 | DNA methylase inhibitor | 0.282 0.034 DBMET02254 0.327 0.021 DBMET02256 0.305 0.026 DBMET02242 0.372 0.014 DBMET02245 0.161 0.108 DBMET02244 0.161 0.108 DBMET02247 0.211 0.072 DBMET02249 0.472 0.007 DBMET02250 0.297 0.029 DBMET02252 0.156 0.112 DBMET02255 0.197 0.081 DBMET02251 | DBMET02250 | |
| 0.281 | 0.015 | 0.488 | Antiadrenergic | 0.251 0.017 DBMET02254 0.234 0.019 DBMET02256 0.275 0.015 DBMET02242 0.416 0.008 DBMET02245 0.076 0.074 DBMET02244 0.076 0.074 DBMET02247 0.104 0.054 DBMET02249 0.488 0.005 DBMET02250 0.198 0.025 DBMET02252 | DBMET02250 | |
| 0.279 | 0.015 | 0.475 | Adrenaline antagonist | 0.249 0.017 DBMET02254 0.232 0.019 DBMET02256 0.273 0.015 DBMET02242 0.416 0.008 DBMET02245 0.074 0.073 DBMET02244 0.074 0.073 DBMET02247 0.102 0.053 DBMET02249 0.475 0.006 DBMET02250 0.196 0.024 DBMET02252 | DBMET02250 | |
| 0.286 | 0.048 | 0.501 | Cyclic AMP phosphodiesterase inhibitor | 0.227 0.076 DBMET02254 0.296 0.043 DBMET02256 0.293 0.045 DBMET02242 0.501 0.006 DBMET02245 0.179 0.112 DBMET02244 0.179 0.112 DBMET02247 0.225 0.077 DBMET02249 0.435 0.012 DBMET02250 0.219 0.081 DBMET02252 | DBMET02245 | |
| 0.228 | 0.014 | 0.252 | Toll-Like receptor 2 antagonist | 0.219 0.016 DBMET02254 0.241 0.011 DBMET02256 0.252 0.009 DBMET02242 0.244 0.01 DBMET02245 0.133 0.065 DBMET02244 0.133 0.065 DBMET02247 0.193 0.027 DBMET02248 0.198 0.024 DBMET02249 0.252 0.009 DBMET02250 0.227 0.014 DBMET02252 0.146 0.055 DBMET02255 0.216 0.017 DBMET02251 | DBMET02250 | |
| 0.213 | 0.025 | 0.213 | Calcium channel blocker | 0.139 0.069 DBMET02254 0.151 0.057 DBMET02256 0.152 0.056 DBMET02242 0.113 0.096 DBMET02245 0.136 0.071 DBMET02244 0.136 0.071 DBMET02247 0.14 0.068 DBMET02249 0.159 0.051 DBMET02250 0.132 0.074 DBMET02252 | ||
| 0.279 | 0.099 | 0.381 | Sodium/bile acid cotransporter inhibitor | 0.299 0.08 DBMET02254 0.297 0.082 DBMET02256 0.292 0.087 DBMET02242 0.381 0.024 DBMET02245 0.267 0.11 DBMET02248 0.353 0.038 DBMET02250 0.236 0.144 DBMET02252 0.353 0.038 DBMET02251 | DBMET02245 | |
| 0.247 | 0.07 | 0.495 | Vasodilator | 0.222 0.088 DBMET02254 0.262 0.063 DBMET02256 0.276 0.057 DBMET02242 0.495 0.012 DBMET02245 0.183 0.119 DBMET02249 0.408 0.022 DBMET02250 0.23 0.082 DBMET02252 | DBMET02245 | |
| 0.213 | 0.064 | 0.289 | Neurotrophic factor enhancer | 0.226 0.054 DBMET02254 0.252 0.037 DBMET02256 0.274 0.027 DBMET02242 0.24 0.044 DBMET02245 0.231 0.051 DBMET02244 0.231 0.051 DBMET02247 0.289 0.021 DBMET02248 0.23 0.052 DBMET02249 0.204 0.072 DBMET02250 0.236 0.047 DBMET02252 0.264 0.031 DBMET02255 0.252 0.037 DBMET02251 | DBMET02248 | |
| 0.246 | 0.107 | 0.305 | Ca(v)3.3 blocker | 0.208 0.175 DBMET02254 0.208 0.175 DBMET02256 0.221 0.15 DBMET02242 0.305 0.038 DBMET02244 0.305 0.038 DBMET02247 0.225 0.142 DBMET02249 0.208 0.175 DBMET02252 0.232 0.13 DBMET02255 | DBMET02247 | |
| 0.272 | 0.134 | 0.419 | Calpain 2 inhibitor | 0.227 0.166 DBMET02256 0.232 0.162 DBMET02242 0.287 0.122 DBMET02244 0.287 0.122 DBMET02247 0.419 0.051 DBMET02248 0.256 0.145 DBMET02249 0.298 0.115 DBMET02251 | DBMET02248 | |
| 0.216 | 0.084 | 0.517 | Hypolipemic | 0.195 0.098 DBMET02254 0.209 0.088 DBMET02256 0.233 0.075 DBMET02242 0.316 0.044 DBMET02245 0.35 0.035 DBMET02248 0.26 0.063 DBMET02249 0.24 0.072 DBMET02250 0.215 0.085 DBMET02252 0.517 0.011 DBMET02251 | DBMET02251 | |
| 0.182 | 0.055 | 0.216 | ATPase inhibitor | 0.174 0.065 DBMET02254 0.181 0.056 DBMET02256 0.188 0.048 DBMET02242 0.216 0.026 DBMET02245 0.191 0.046 DBMET02248 0.171 0.069 DBMET02249 0.207 0.032 DBMET02250 0.172 0.067 DBMET02251 | DBMET02245 | |
| 0.177 | 0.052 | 0.621 | Amylase inhibitor | 0.197 0.045 DBMET02254 0.254 0.027 DBMET02256 0.228 0.035 DBMET02242 0.621 0.004 DBMET02245 0.157 0.06 DBMET02248 0.201 0.044 DBMET02249 0.268 0.023 DBMET02250 0.216 0.039 DBMET02252 0.178 0.052 DBMET02251 | DBMET02245 | |
| 0.198 | 0.076 | 0.289 | Insulin sensitizer | 0.171 0.106 DBMET02254 0.197 0.076 DBMET02256 0.216 0.058 DBMET02242 0.274 0.023 DBMET02245 0.181 0.094 DBMET02248 0.154 0.128 DBMET02249 0.289 0.018 DBMET02250 0.174 0.102 DBMET02252 0.234 0.044 DBMET02251 | DBMET02250 | |
| 0.127 | 0.009 | 0.147 | Beta adrenoreceptor antagonist | 0.12 0.01 DBMET02254 0.14 0.007 DBMET02256 0.147 0.006 DBMET02242 0.142 0.006 DBMET02245 0.078 0.029 DBMET02248 0.077 0.03 DBMET02249 0.134 0.008 DBMET02250 0.108 0.014 DBMET02252 | DBMET02242 | |
| 0.304 | 0.189 | 0.749 | Caspase 9 stimulant | 0.366 0.134 DBMET02256 0.299 0.195 DBMET02242 0.749 0.018 DBMET02245 0.328 0.165 DBMET02244 0.328 0.165 DBMET02247 0.381 0.122 DBMET02248 0.296 0.199 DBMET02249 0.537 0.048 DBMET02250 0.317 0.176 DBMET02252 0.301 0.193 DBMET02255 0.422 0.098 DBMET02251 | DBMET02245 | |
| 0.148 | 0.033 | 0.398 | Mucolytic | 0.144 0.036 DBMET02254 0.155 0.03 DBMET02256 0.15 0.032 DBMET02242 0.398 0.003 DBMET02245 0.15 0.033 DBMET02248 0.128 0.047 DBMET02249 0.325 0.004 DBMET02250 0.154 0.03 DBMET02252 0.165 0.025 DBMET02251 | DBMET02245 | |
| 0.133 | 0.02 | 0.196 | Adrenaline agonist | 0.174 0.01 DBMET02254 0.162 0.012 DBMET02256 0.196 0.007 DBMET02242 0.139 0.018 DBMET02245 0.074 0.066 DBMET02244 0.074 0.066 DBMET02247 0.089 0.047 DBMET02248 0.092 0.043 DBMET02249 0.134 0.02 DBMET02250 0.138 0.018 DBMET02252 0.128 0.022 DBMET02255 | DBMET02242 | |
| 0.19 | 0.08 | 0.426 | Anesthetic general | 0.165 0.099 DBMET02254 0.164 0.1 DBMET02256 0.199 0.075 DBMET02242 0.325 0.028 DBMET02245 0.235 0.057 DBMET02244 0.235 0.057 DBMET02247 0.398 0.017 DBMET02248 0.238 0.056 DBMET02249 0.238 0.056 DBMET02250 0.136 0.129 DBMET02252 0.216 0.066 DBMET02255 0.426 0.014 DBMET02251 | DBMET02251 | |
| 0.137 | 0.031 | 0.171 | Urease inhibitor | 0.133 0.034 DBMET02254 0.158 0.02 DBMET02256 0.153 0.021 DBMET02242 0.104 0.062 DBMET02245 0.117 0.048 DBMET02244 0.117 0.048 DBMET02247 0.171 0.015 DBMET02248 0.116 0.049 DBMET02249 0.107 0.059 DBMET02250 0.102 0.065 DBMET02252 0.116 0.049 DBMET02255 0.14 0.028 DBMET02251 | DBMET02248 | |
| 0.143 | 0.04 | 0.249 | Sphingosine 1-phosphate receptor 4 antagonist | 0.111 0.09 DBMET02254 0.116 0.079 DBMET02256 0.127 0.06 DBMET02242 0.192 0.011 DBMET02245 0.158 0.027 DBMET02244 0.158 0.027 DBMET02247 0.238 0.005 DBMET02248 0.177 0.016 DBMET02249 0.16 0.025 DBMET02252 0.128 0.058 DBMET02255 0.249 0.005 DBMET02251 | DBMET02251 | |
| 0.147 | 0.045 | 0.211 | Sphingosine 1-phosphate receptor 2 antagonist | 0.12 0.098 DBMET02254 0.147 0.045 DBMET02256 0.16 0.03 DBMET02242 0.135 0.064 DBMET02245 0.174 0.019 DBMET02244 0.174 0.019 DBMET02247 0.197 0.008 DBMET02248 0.167 0.023 DBMET02249 0.125 0.084 DBMET02250 0.131 0.072 DBMET02252 0.156 0.034 DBMET02255 0.211 0.005 DBMET02251 | DBMET02251 | |
| 0.112 | 0.012 | 0.141 | Beta 3 adrenoreceptor antagonist | 0.1 0.015 DBMET02254 0.12 0.01 DBMET02256 0.135 0.007 DBMET02242 0.141 0.007 DBMET02245 0.069 0.036 DBMET02248 0.073 0.03 DBMET02249 0.118 0.01 DBMET02250 0.083 0.022 DBMET02252 | DBMET02245 | |
| 0.14 | 0.04 | 0.485 | Expectorant | 0.136 0.041 DBMET02254 0.149 0.036 DBMET02256 0.142 0.039 DBMET02242 0.485 0.004 DBMET02245 0.123 0.049 DBMET02248 0.108 0.061 DBMET02249 0.381 0.005 DBMET02250 0.146 0.037 DBMET02252 0.144 0.038 DBMET02251 | DBMET02245 | |
| 0.29 | 0.191 | 0.29 | MAP kinase 1 inhibitor | 0.261 0.221 DBMET02254 0.249 0.234 DBMET02256 0.271 0.211 DBMET02245 0.28 0.202 DBMET02248 | ||
| 0.135 | 0.036 | 0.281 | Mediator release inhibitor | 0.119 0.048 DBMET02254 0.158 0.025 DBMET02256 0.163 0.024 DBMET02242 0.252 0.009 DBMET02245 0.093 0.078 DBMET02248 0.122 0.046 DBMET02249 0.281 0.008 DBMET02250 0.104 0.065 DBMET02252 0.108 0.06 DBMET02251 | DBMET02250 | |
| 0.207 | 0.109 | 0.488 | Superoxide dismutase inhibitor | 0.208 0.108 DBMET02254 0.244 0.078 DBMET02256 0.227 0.091 DBMET02242 0.488 0.014 DBMET02245 0.3 0.05 DBMET02244 0.3 0.05 DBMET02247 0.239 0.082 DBMET02248 0.181 0.14 DBMET02249 0.466 0.017 DBMET02250 0.334 0.04 DBMET02255 0.249 0.075 DBMET02251 | DBMET02245 | |
| 0.151 | 0.053 | 0.167 | Nav1.6 sodium channel blocker | 0.13 0.081 DBMET02256 0.132 0.078 DBMET02242 0.167 0.037 DBMET02245 0.13 0.081 DBMET02244 0.13 0.081 DBMET02247 0.153 0.051 DBMET02249 0.146 0.058 DBMET02250 0.112 0.109 DBMET02252 | DBMET02245 | |
| 0.158 | 0.063 | 0.22 | Lipid peroxidase inhibitor | 0.186 0.047 DBMET02254 0.207 0.039 DBMET02256 0.22 0.034 DBMET02242 0.121 0.093 DBMET02245 0.112 0.102 DBMET02248 0.124 0.09 DBMET02249 0.204 0.04 DBMET02250 0.153 0.066 DBMET02252 0.176 0.052 DBMET02255 0.112 0.103 DBMET02251 | DBMET02242 | |
| 0.135 | 0.043 | 0.135 | Calcium channel (voltage-sensitive) blocker | 0.103 0.079 DBMET02242 0.113 0.065 DBMET02244 0.113 0.065 DBMET02247 0.107 0.074 DBMET02249 | ||
| 0.098 | 0.01 | 0.13 | Beta 1 adrenoreceptor antagonist | 0.086 0.015 DBMET02254 0.102 0.01 DBMET02256 0.113 0.008 DBMET02242 0.13 0.006 DBMET02245 0.062 0.034 DBMET02249 0.117 0.007 DBMET02250 0.079 0.018 DBMET02252 | DBMET02245 | |
| 0.112 | 0.026 | 0.129 | ATPase (Vacuolar H+) inhibitor | 0.111 0.027 DBMET02254 0.108 0.029 DBMET02256 0.113 0.025 DBMET02242 0.128 0.015 DBMET02245 0.098 0.042 DBMET02249 0.129 0.014 DBMET02250 0.103 0.035 DBMET02252 | DBMET02250 | |
| 0.202 | 0.119 | 0.379 | Interleukin agonist | 0.176 0.143 DBMET02254 0.185 0.135 DBMET02256 0.247 0.081 DBMET02242 0.27 0.065 DBMET02245 0.282 0.057 DBMET02244 0.282 0.057 DBMET02247 0.352 0.028 DBMET02248 0.275 0.062 DBMET02249 0.275 0.062 DBMET02250 0.226 0.097 DBMET02252 0.265 0.068 DBMET02255 0.379 0.022 DBMET02251 | DBMET02251 | |
| 0.094 | 0.015 | 0.305 | Acetyl-CoA transferase inhibitor | 0.083 0.019 DBMET02254 0.086 0.018 DBMET02256 0.091 0.016 DBMET02242 0.188 0.005 DBMET02244 0.188 0.005 DBMET02247 0.216 0.004 DBMET02248 0.114 0.01 DBMET02249 0.089 0.017 DBMET02252 0.129 0.008 DBMET02255 0.305 0.004 DBMET02251 | DBMET02251 | |
| 0.093 | 0.018 | 0.095 | Calcium channel T-type blocker | 0.057 0.042 DBMET02254 0.062 0.035 DBMET02256 0.064 0.032 DBMET02242 0.095 0.018 DBMET02244 0.095 0.018 DBMET02247 0.073 0.026 DBMET02249 | DBMET02247 | |
| 0.118 | 0.046 | 0.158 | Toll-Like receptor 4 antagonist | 0.115 0.049 DBMET02254 0.127 0.037 DBMET02256 0.12 0.044 DBMET02242 0.157 0.017 DBMET02245 0.132 0.033 DBMET02248 0.158 0.017 DBMET02250 0.113 0.051 DBMET02252 0.102 0.066 DBMET02251 | DBMET02250 | |
| 0.081 | 0.014 | 0.185 | Calcium channel P-type blocker | 0.061 0.052 DBMET02254 0.061 0.052 DBMET02256 0.185 0.003 DBMET02245 0.109 0.005 DBMET02250 0.062 0.05 DBMET02252 | DBMET02245 | |
| 0.149 | 0.085 | 0.27 | Sigma receptor agonist | 0.124 0.109 DBMET02254 0.148 0.087 DBMET02256 0.27 0.045 DBMET02244 0.27 0.045 DBMET02247 0.119 0.116 DBMET02249 0.159 0.079 DBMET02255 | DBMET02247 | |
| 0.146 | 0.083 | 0.214 | Hexokinase inhibitor | 0.175 0.053 DBMET02254 0.169 0.059 DBMET02256 0.151 0.078 DBMET02242 0.2 0.035 DBMET02245 0.129 0.106 DBMET02244 0.129 0.106 DBMET02247 0.18 0.049 DBMET02248 0.214 0.028 DBMET02249 0.121 0.117 DBMET02250 0.132 0.101 DBMET02252 0.168 0.06 DBMET02255 0.176 0.052 DBMET02251 | DBMET02249 | |
| 0.187 | 0.125 | 0.461 | Hypoglycemic | 0.175 0.141 DBMET02254 0.226 0.092 DBMET02256 0.223 0.094 DBMET02242 0.461 0.019 DBMET02245 0.17 0.148 DBMET02248 0.196 0.116 DBMET02249 0.241 0.082 DBMET02250 0.225 0.093 DBMET02252 0.23 0.089 DBMET02251 | DBMET02245 | |
| 0.112 | 0.051 | 0.214 | Gastric antisecretory | 0.096 0.071 DBMET02256 0.101 0.065 DBMET02242 0.214 0.01 DBMET02245 0.153 0.026 DBMET02248 0.104 0.061 DBMET02250 0.124 0.04 DBMET02252 0.131 0.036 DBMET02251 | DBMET02245 | |
| 0.139 | 0.084 | 0.163 | Neuropeptide Y1 antagonist | 0.136 0.088 DBMET02256 0.124 0.113 DBMET02242 0.163 0.047 DBMET02244 0.163 0.047 DBMET02247 0.123 0.115 DBMET02249 0.133 0.094 DBMET02250 0.134 0.093 DBMET02255 | DBMET02247 | |
| 0.191 | 0.137 | 0.237 | Neuropeptide Y2 antagonist | 0.177 0.166 DBMET02256 0.192 0.134 DBMET02242 0.185 0.15 DBMET02245 0.236 0.071 DBMET02244 0.236 0.071 DBMET02247 0.227 0.08 DBMET02248 0.211 0.102 DBMET02249 0.184 0.151 DBMET02255 0.237 0.069 DBMET02251 | DBMET02251 | |
| 0.067 | 0.018 | 0.096 | Beta 2 adrenoreceptor antagonist | 0.063 0.021 DBMET02254 0.078 0.012 DBMET02256 0.087 0.01 DBMET02242 0.096 0.008 DBMET02245 0.051 0.036 DBMET02248 0.087 0.01 DBMET02250 0.055 0.03 DBMET02252 | DBMET02245 | |
| 0.205 | 0.16 | 0.701 | Cholesterol antagonist | 0.194 0.17 DBMET02254 0.189 0.175 DBMET02256 0.259 0.119 DBMET02242 0.701 0.008 DBMET02245 0.268 0.113 DBMET02248 0.217 0.15 DBMET02249 0.474 0.037 DBMET02250 0.231 0.139 DBMET02252 0.344 0.067 DBMET02251 | DBMET02245 | |
| 0.101 | 0.056 | 0.208 | MAP kinase kinase 1 inhibitor | 0.089 0.072 DBMET02254 0.109 0.046 DBMET02242 0.208 0.004 DBMET02245 0.148 0.017 DBMET02248 0.151 0.016 DBMET02249 0.096 0.062 DBMET02250 | DBMET02245 | |
| 0.071 | 0.026 | 0.088 | Kallikrein 7 inhibitor | 0.066 0.036 DBMET02254 0.068 0.033 DBMET02256 0.065 0.04 DBMET02242 0.088 0.008 DBMET02244 0.088 0.008 DBMET02247 0.069 0.029 DBMET02249 0.067 0.036 DBMET02252 0.078 0.016 DBMET02255 | DBMET02247 | |
| 0.123 | 0.08 | 0.161 | Toll-Like receptor antagonist | 0.11 0.102 DBMET02256 0.13 0.072 DBMET02242 0.161 0.048 DBMET02244 0.161 0.048 DBMET02247 0.158 0.05 DBMET02248 0.127 0.075 DBMET02250 0.116 0.091 DBMET02252 | DBMET02247 | |
| 0.095 | 0.052 | 0.187 | Glutamate release inhibitor | 0.085 0.075 DBMET02254 0.146 0.011 DBMET02245 0.187 0.005 DBMET02250 0.099 0.044 DBMET02252 0.104 0.037 DBMET02251 | DBMET02250 | |
| 0.119 | 0.078 | 0.545 | Alpha-N-acetylglucosaminidase inhibitor | 0.166 0.047 DBMET02242 0.545 0.004 DBMET02245 0.179 0.041 DBMET02244 0.179 0.041 DBMET02247 0.467 0.006 DBMET02248 0.463 0.006 DBMET02249 0.29 0.017 DBMET02250 0.11 0.088 DBMET02252 0.138 0.062 DBMET02255 0.506 0.005 DBMET02251 | DBMET02245 | |
| 0.054 | 0.013 | 0.212 | Acetyl-CoA transferase 1 inhibitor | 0.048 0.019 DBMET02254 0.051 0.015 DBMET02256 0.052 0.015 DBMET02242 0.098 0.005 DBMET02244 0.098 0.005 DBMET02247 0.11 0.004 DBMET02248 0.059 0.009 DBMET02249 0.053 0.014 DBMET02252 0.062 0.009 DBMET02255 0.212 0.003 DBMET02251 | DBMET02251 | |
| 0.176 | 0.135 | 0.285 | Peptidyltransferase inhibitor | 0.172 0.142 DBMET02254 0.183 0.123 DBMET02256 0.213 0.084 DBMET02242 0.257 0.046 DBMET02245 0.285 0.031 DBMET02248 0.226 0.07 DBMET02249 0.187 0.118 DBMET02250 0.261 0.044 DBMET02251 | DBMET02248 | |
| 0.107 | 0.067 | 0.138 | Multidrug resistance-associated protein 1 inhibitor | 0.117 0.052 DBMET02256 0.102 0.075 DBMET02242 0.138 0.032 DBMET02250 | DBMET02250 | |
| 0.111 | 0.073 | 0.151 | Sphingosine 1-phosphate receptor 2 agonist | 0.103 0.093 DBMET02256 0.107 0.083 DBMET02242 0.151 0.025 DBMET02245 0.104 0.09 DBMET02249 0.131 0.04 DBMET02250 | DBMET02245 | |
| 0.078 | 0.042 | 0.098 | Calcium channel L-type blocker | 0.098 0.026 DBMET02245 0.091 0.03 DBMET02250 | DBMET02245 | |
| 0.043 | 0.009 | 0.068 | Adenosine uptake inhibitor | 0.034 0.026 DBMET02254 0.034 0.026 DBMET02256 0.037 0.018 DBMET02242 0.068 0.003 DBMET02244 0.068 0.003 DBMET02247 0.046 0.006 DBMET02248 0.046 0.006 DBMET02249 0.035 0.023 DBMET02252 0.045 0.006 DBMET02255 0.039 0.013 DBMET02251 | DBMET02247 | |
| 0.096 | 0.061 | 0.147 | Phosphodiesterase 6D inhibitor | 0.096 0.061 DBMET02256 0.112 0.033 DBMET02242 0.147 0.01 DBMET02245 0.09 0.074 DBMET02249 0.112 0.034 DBMET02250 | DBMET02245 | |
| 0.099 | 0.071 | 0.139 | Falcipain 3 inhibitor | 0.099 0.071 DBMET02256 0.093 0.078 DBMET02242 0.094 0.077 DBMET02245 0.139 0.042 DBMET02244 0.139 0.042 DBMET02247 0.139 0.042 DBMET02248 0.125 0.05 DBMET02249 0.093 0.078 DBMET02250 0.113 0.059 DBMET02255 0.118 0.055 DBMET02251 | DBMET02248 | |
| 0.188 | 0.165 | 0.267 | 12-Lipoxygenase inhibitor | 0.217 0.133 DBMET02254 0.267 0.1 DBMET02256 0.25 0.109 DBMET02242 0.193 0.16 DBMET02245 0.266 0.1 DBMET02248 0.208 0.142 DBMET02255 0.238 0.116 DBMET02251 | DBMET02256 | |
| 0.173 | 0.149 | 0.63 | 5 Hydroxytryptamine release stimulant | 0.63 0.012 DBMET02245 0.219 0.107 DBMET02244 0.219 0.107 DBMET02247 0.174 0.147 DBMET02248 0.44 0.038 DBMET02250 0.168 0.156 DBMET02251 | DBMET02245 | |
| 0.136 | 0.113 | 0.396 | Interleukin 6 antagonist | 0.141 0.103 DBMET02254 0.146 0.095 DBMET02256 0.15 0.089 DBMET02242 0.396 0.008 DBMET02245 0.135 0.115 DBMET02248 0.134 0.117 DBMET02249 0.147 0.093 DBMET02250 | DBMET02245 | |
| 0.155 | 0.133 | 0.205 | MAP kinase kinase 5 inhibitor | 0.205 0.028 DBMET02245 0.16 0.114 DBMET02244 0.16 0.114 DBMET02247 0.154 0.138 DBMET02248 0.193 0.041 DBMET02249 | DBMET02245 | |
| 0.047 | 0.025 | 0.061 | Beta adrenoreceptor agonist | 0.053 0.014 DBMET02254 0.053 0.014 DBMET02256 0.061 0.008 DBMET02242 0.053 0.013 DBMET02245 0.045 0.033 DBMET02248 0.043 0.041 DBMET02249 0.049 0.019 DBMET02250 0.048 0.021 DBMET02252 | DBMET02242 | |
| 0.11 | 0.088 | 0.164 | M17 leucyl aminopeptidase inhibitor | 0.102 0.1 DBMET02254 0.104 0.097 DBMET02256 0.116 0.082 DBMET02242 0.124 0.074 DBMET02244 0.124 0.074 DBMET02247 0.111 0.087 DBMET02248 0.121 0.076 DBMET02255 0.164 0.047 DBMET02251 | DBMET02251 | |
| 0.074 | 0.053 | 0.116 | Phosphodiesterase VI inhibitor | 0.073 0.054 DBMET02256 0.116 0.013 DBMET02245 0.074 0.052 DBMET02250 | DBMET02245 | |
| 0.09 | 0.069 | 0.096 | Toll-Like receptor 3 antagonist | 0.096 0.057 DBMET02245 0.089 0.071 DBMET02248 0.089 0.072 DBMET02252 | DBMET02245 | |
| 0.127 | 0.108 | 0.213 | Sphingosine 1-phosphate receptor 5 antagonist | 0.148 0.065 DBMET02242 0.183 0.021 DBMET02245 0.164 0.041 DBMET02244 0.164 0.041 DBMET02247 0.212 0.007 DBMET02248 0.167 0.037 DBMET02249 0.144 0.071 DBMET02255 0.213 0.007 DBMET02251 | DBMET02251 | |
| 0.17 | 0.153 | 0.297 | Nitric-oxide synthase stimulant | 0.191 0.106 DBMET02256 0.189 0.11 DBMET02242 0.297 0.012 DBMET02245 0.205 0.08 DBMET02248 0.202 0.086 DBMET02250 0.171 0.15 DBMET02252 0.2 0.088 DBMET02251 | DBMET02245 | |
| 0.156 | 0.139 | 0.262 | Free radical scavenger | 0.207 0.092 DBMET02254 0.258 0.065 DBMET02256 0.257 0.066 DBMET02242 0.217 0.085 DBMET02245 0.262 0.064 DBMET02250 0.159 0.135 DBMET02252 0.159 0.135 DBMET02255 | DBMET02250 | |
| 0.1 | 0.083 | 0.154 | Electron transport complex I inhibitor | 0.098 0.087 DBMET02256 0.154 0.018 DBMET02245 0.107 0.068 DBMET02250 | DBMET02245 | |
| 0.084 | 0.068 | 0.148 | Alpha adrenoreceptor antagonist | 0.148 0.038 DBMET02250 | DBMET02250 | |
| 0.136 | 0.12 | 0.25 | Amyloid beta aggregation inhibitor | 0.25 0.058 DBMET02254 0.213 0.071 DBMET02256 0.204 0.076 DBMET02242 0.225 0.066 DBMET02245 0.225 0.066 DBMET02250 0.173 0.093 DBMET02255 | DBMET02254 | |
| 0.058 | 0.042 | 0.097 | Alpha 1d adrenoreceptor antagonist | 0.097 0.024 DBMET02250 | DBMET02250 | |
| 0.02 | 0.008 | 0.072 | Calcium-sensing receptor antagonist | 0.016 0.01 DBMET02254 0.017 0.009 DBMET02256 0.02 0.008 DBMET02242 0.072 0.004 DBMET02245 0.065 0.005 DBMET02250 0.015 0.011 DBMET02252 | DBMET02245 | |
| 0.12 | 0.111 | 0.454 | Insulin secretagoues | 0.117 0.116 DBMET02256 0.136 0.089 DBMET02242 0.454 0.005 DBMET02245 0.131 0.096 DBMET02249 0.18 0.048 DBMET02250 0.125 0.104 DBMET02251 | DBMET02245 | |
| 0.084 | 0.075 | 0.12 | Breast cancer-resistant protein inhibitor | 0.083 0.076 DBMET02254 0.102 0.053 DBMET02256 0.12 0.039 DBMET02245 0.11 0.047 DBMET02250 | DBMET02245 | |
| 0.047 | 0.04 | 0.228 | Dopamine D4 agonist | 0.045 0.043 DBMET02242 0.228 0.005 DBMET02244 0.228 0.005 DBMET02247 0.083 0.019 DBMET02255 | DBMET02247 | |
| 0.267 | 0.261 | 0.52 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.298 0.216 DBMET02245 0.52 0.025 DBMET02244 0.52 0.025 DBMET02247 0.402 0.098 DBMET02248 0.356 0.144 DBMET02249 0.384 0.115 DBMET02255 0.395 0.105 DBMET02251 | DBMET02247 | |
| 0.067 | 0.061 | 0.141 | Alpha 1 adrenoreceptor antagonist | 0.141 0.031 DBMET02250 | DBMET02250 | |
| 0.093 | 0.087 | 0.156 | Nav1.4 sodium channel blocker | 0.099 0.077 DBMET02256 0.105 0.069 DBMET02242 0.096 0.082 DBMET02244 0.096 0.082 DBMET02247 0.115 0.057 DBMET02248 0.096 0.083 DBMET02249 0.099 0.078 DBMET02252 0.092 0.089 DBMET02255 0.156 0.031 DBMET02251 | DBMET02251 | |
| 0.139 | 0.134 | 0.359 | Succinate dehydrogenase inhibitor | 0.151 0.11 DBMET02242 0.359 0.005 DBMET02245 0.268 0.017 DBMET02248 0.16 0.096 DBMET02249 0.265 0.018 DBMET02250 0.138 0.136 DBMET02255 0.331 0.007 DBMET02251 | DBMET02245 | |
| 0.029 | 0.025 | 0.055 | Cholesterol ester transfer protein antagonist | 0.055 0.005 DBMET02245 0.032 0.021 DBMET02250 | DBMET02245 | |
| 0.045 | 0.043 | 0.069 | Bombesin 2 receptor antagonist | 0.047 0.037 DBMET02245 0.058 0.026 DBMET02244 0.058 0.026 DBMET02247 0.048 0.037 DBMET02248 0.052 0.031 DBMET02249 0.069 0.02 DBMET02250 0.051 0.033 DBMET02255 0.048 0.036 DBMET02251 | DBMET02250 | |
| 0.029 | 0.028 | 0.174 | Sphingosine 1-phosphate receptor 3 agonist | 0.034 0.024 DBMET02242 0.174 0.004 DBMET02245 0.033 0.025 DBMET02248 0.036 0.023 DBMET02249 0.063 0.011 DBMET02250 | DBMET02245 | |
| 0.104 | 0.107 | 0.117 | Sodium channel blocker | 0.117 0.088 DBMET02245 | DBMET02245 | |
| 0.126 | 0.13 | 0.283 | Antipruritic | 0.137 0.112 DBMET02242 0.283 0.017 DBMET02244 0.283 0.017 DBMET02247 0.24 0.028 DBMET02248 0.174 0.07 DBMET02249 0.204 0.046 DBMET02255 0.194 0.053 DBMET02251 | DBMET02247 | |
| 0.057 | 0.066 | 0.069 | Beta 2 adrenoreceptor agonist | 0.065 0.033 DBMET02254 0.063 0.038 DBMET02256 0.068 0.022 DBMET02242 0.069 0.021 DBMET02245 0.069 0.02 DBMET02248 0.058 0.057 DBMET02250 0.06 0.05 DBMET02252 0.062 0.042 DBMET02255 | DBMET02248 | |
| 0.109 | 0.118 | 0.177 | Vanilloid 1 agonist | 0.112 0.108 DBMET02256 0.113 0.106 DBMET02242 0.172 0.022 DBMET02245 0.177 0.02 DBMET02248 0.154 0.034 DBMET02250 0.121 0.085 DBMET02252 0.153 0.035 DBMET02251 | DBMET02248 | |
| 0.046 | 0.056 | 0.05 | Alpha 1L adrenoreceptor antagonist | 0.05 0.041 DBMET02250 | DBMET02250 | |
| 0.024 | 0.035 | 0.047 | Lysophosphatidic acid 2 receptor antagonist | 0.045 0.01 DBMET02245 0.047 0.009 DBMET02248 0.036 0.015 DBMET02250 0.039 0.013 DBMET02251 | DBMET02248 | |
| 0.118 | 0.131 | 0.179 | Dual specificity phosphatase 3 inhibitor | 0.143 0.102 DBMET02254 0.137 0.108 DBMET02256 0.155 0.092 DBMET02242 0.171 0.08 DBMET02255 0.179 0.074 DBMET02251 | DBMET02251 | |
| 0.108 | 0.121 | 0.132 | Papain-like protease (SARS coronavirus) inhibitor | 0.124 0.072 DBMET02254 0.119 0.085 DBMET02256 0.121 0.08 DBMET02242 0.115 0.095 DBMET02248 0.132 0.056 DBMET02255 0.119 0.083 DBMET02251 | DBMET02255 | |
| 0.08 | 0.094 | 0.086 | Insulin receptor antagonist | 0.086 0.085 DBMET02245 | DBMET02245 | |
| 0.033 | 0.047 | 0.11 | Sphingosine 1-phosphate receptor 1 agonist | 0.11 0.004 DBMET02245 0.046 0.024 DBMET02248 0.047 0.023 DBMET02249 0.071 0.008 DBMET02250 0.055 0.016 DBMET02251 | DBMET02245 | |
| 0.15 | 0.165 | 0.299 | Antioxidant | 0.215 0.104 DBMET02254 0.244 0.087 DBMET02256 0.241 0.089 DBMET02242 0.299 0.062 DBMET02245 0.261 0.078 DBMET02250 0.173 0.139 DBMET02252 0.158 0.156 DBMET02255 | DBMET02245 | |
| 0.086 | 0.102 | 0.217 | Interleukin 1b antagonist | 0.217 0.016 DBMET02245 0.125 0.059 DBMET02252 | DBMET02245 | |
| 0.047 | 0.063 | 0.08 | Bombesin 1 receptor agonist | 0.08 0.025 DBMET02244 0.08 0.025 DBMET02247 0.066 0.035 DBMET02248 0.053 0.051 DBMET02249 0.061 0.039 DBMET02255 0.059 0.042 DBMET02251 | DBMET02247 | |
| 0.02 | 0.037 | 0.028 | 5 Hydroxytryptamine 4 agonist | 0.028 0.009 DBMET02250 | DBMET02250 | |
| 0.072 | 0.089 | 0.097 | Ca(v)3.1 blocker | 0.097 0.026 DBMET02244 0.097 0.026 DBMET02247 0.087 0.043 DBMET02255 | DBMET02247 | |
| 0.004 | 0.022 | 0.037 | Mannitol 2-dehydrogenase inhibitor | 0.037 0.001 DBMET02245 0.017 0.003 DBMET02249 | DBMET02245 | |
| 0.189 | 0.209 | 0.374 | Interleukin 2 agonist | 0.216 0.163 DBMET02254 0.201 0.188 DBMET02256 0.22 0.157 DBMET02242 0.203 0.184 DBMET02245 0.351 0.045 DBMET02248 0.258 0.11 DBMET02249 0.21 0.173 DBMET02250 0.265 0.103 DBMET02252 0.25 0.118 DBMET02255 0.374 0.036 DBMET02251 | DBMET02251 | |
| 0.194 | 0.22 | 0.29 | 15-Lipoxygenase inhibitor | 0.213 0.199 DBMET02254 0.29 0.138 DBMET02256 0.29 0.138 DBMET02242 0.258 0.158 DBMET02248 0.227 0.185 DBMET02255 0.212 0.2 DBMET02251 | DBMET02242 | |
| 0.048 | 0.073 | 0.096 | Alpha 1b adrenoreceptor antagonist | 0.096 0.037 DBMET02250 | DBMET02250 | |
| 0.071 | 0.098 | 0.232 | NADH dehydrogenase inhibitor | 0.084 0.067 DBMET02242 0.232 0.009 DBMET02245 0.114 0.032 DBMET02248 0.139 0.021 DBMET02249 0.152 0.017 DBMET02250 0.121 0.028 DBMET02251 | DBMET02245 | |
| 0.047 | 0.074 | 0.07 | Heat shock protein 90 beta antagonist | 0.056 0.047 DBMET02254 0.07 0.028 DBMET02256 0.061 0.038 DBMET02242 0.06 0.04 DBMET02245 0.055 0.05 DBMET02248 0.054 0.052 DBMET02250 0.056 0.047 DBMET02255 | DBMET02256 | |
| 0.084 | 0.111 | 0.266 | Cholesterol synthesis inhibitor | 0.098 0.091 DBMET02242 0.266 0.015 DBMET02245 0.235 0.02 DBMET02250 0.106 0.08 DBMET02251 | DBMET02245 | |
| 0.078 | 0.105 | 0.125 | Interleukin 12 antagonist | 0.094 0.064 DBMET02256 0.106 0.045 DBMET02248 0.125 0.025 DBMET02251 | DBMET02251 | |
| 0.021 | 0.051 | 0.063 | Methionyl aminopeptidase 1 inhibitor | 0.063 0.005 DBMET02244 0.063 0.005 DBMET02247 0.035 0.017 DBMET02248 0.038 0.014 DBMET02249 0.035 0.017 DBMET02255 0.055 0.005 DBMET02251 | DBMET02247 | |
| 0.05 | 0.08 | 0.236 | Catalase inhibitor | 0.219 0.012 DBMET02245 0.181 0.019 DBMET02248 0.069 0.055 DBMET02249 0.167 0.022 DBMET02250 0.236 0.01 DBMET02251 | DBMET02251 | |
| 0.031 | 0.061 | 0.134 | Sphingosine 1-phosphate receptor agonist | 0.134 0.004 DBMET02245 0.046 0.029 DBMET02248 0.041 0.035 DBMET02249 0.079 0.009 DBMET02250 0.057 0.019 DBMET02251 | DBMET02245 | |
| 0.071 | 0.103 | 0.242 | Sphingomyelinase inhibitor | 0.242 0.005 DBMET02245 0.084 0.081 DBMET02248 0.116 0.044 DBMET02250 | DBMET02245 | |
| 0.031 | 0.063 | 0.046 | Plasmepsin II inhibitor | 0.046 0.022 DBMET02245 | DBMET02245 | |
| 0.033 | 0.066 | 0.04 | DNA gyrase subunit A inhibitor | 0.04 0.036 DBMET02256 0.04 0.037 DBMET02255 | DBMET02255 | |
| 0.069 | 0.103 | 0.388 | Triose-phosphate isomerase inhibitor | 0.084 0.069 DBMET02242 0.388 0.004 DBMET02245 0.085 0.067 DBMET02244 0.085 0.067 DBMET02247 0.231 0.008 DBMET02248 0.185 0.013 DBMET02249 0.15 0.02 DBMET02250 0.308 0.005 DBMET02251 | DBMET02245 | |
| 0.045 | 0.081 | 0.08 | Fibroblast growth factor 2 antagonist | 0.08 0.034 DBMET02245 0.064 0.047 DBMET02250 | DBMET02245 | |
| 0.027 | 0.063 | 0.146 | Phosphorylase inhibitor | 0.085 0.015 DBMET02248 0.113 0.011 DBMET02249 0.146 0.008 DBMET02251 | DBMET02251 | |
| 0.041 | 0.078 | 0.09 | Alpha 1a adrenoreceptor antagonist | 0.09 0.04 DBMET02250 | DBMET02250 | |
| 0.013 | 0.052 | 0.027 | Beta 1 adrenoreceptor agonist | 0.027 0.011 DBMET02245 | DBMET02245 | |
| 0.06 | 0.1 | 0.11 | NMDA receptor antagonist | 0.08 0.066 DBMET02256 0.104 0.045 DBMET02242 0.107 0.043 DBMET02249 0.11 0.041 DBMET02250 0.108 0.042 DBMET02251 | DBMET02250 | |
| 0.025 | 0.065 | 0.042 | Carbonic anhydrase VII inhibitor | 0.041 0.04 DBMET02256 0.042 0.038 DBMET02251 | DBMET02251 | |
| 0.04 | 0.08 | 0.074 | 5 Hydroxytryptamine 1A antagonist | 0.074 0.044 DBMET02250 | DBMET02250 | |
| 0.034 | 0.074 | 0.117 | Maillard reaction inhibitor | 0.049 0.045 DBMET02254 0.05 0.043 DBMET02242 0.107 0.014 DBMET02248 0.051 0.043 DBMET02249 0.08 0.025 DBMET02255 0.117 0.011 DBMET02251 | DBMET02251 | |
| 0.131 | 0.172 | 0.251 | Antiamyloidogenic | 0.2 0.1 DBMET02254 0.178 0.116 DBMET02256 0.151 0.146 DBMET02242 0.226 0.083 DBMET02245 0.251 0.071 DBMET02250 0.154 0.142 DBMET02252 | DBMET02250 | |
| 0.059 | 0.103 | 0.135 | ErbB-3 antagonist | 0.135 0.023 DBMET02245 0.081 0.06 DBMET02251 | DBMET02245 | |
| 0.016 | 0.063 | 0.032 | Vitamin D receptor antagonist | 0.032 0.007 DBMET02245 | DBMET02245 | |
| 0.17 | 0.219 | 0.472 | Antithrombotic | 0.199 0.178 DBMET02242 0.444 0.039 DBMET02245 0.192 0.187 DBMET02248 0.472 0.033 DBMET02250 0.289 0.096 DBMET02251 | DBMET02250 | |
| 0.083 | 0.135 | 0.127 | Acetylcholine release stimulant | 0.127 0.038 DBMET02245 0.12 0.048 DBMET02244 0.12 0.048 DBMET02247 0.104 0.079 DBMET02248 | DBMET02245 | |
| 0.009 | 0.061 | 0.025 | Vitamin D receptor agonist | 0.025 0.004 DBMET02245 | DBMET02245 | |
| 0.062 | 0.114 | 0.089 | Protease inhibitor | 0.089 0.076 DBMET02245 | DBMET02245 | |
| 0.077 | 0.129 | 0.123 | Glutamate (mGluR7) agonist | 0.106 0.049 DBMET02245 0.09 0.083 DBMET02244 0.09 0.083 DBMET02247 0.097 0.066 DBMET02248 0.123 0.028 DBMET02251 | DBMET02251 | |
| 0.037 | 0.09 | 0.094 | Dopamine agonist | 0.069 0.045 DBMET02242 0.088 0.033 DBMET02244 0.088 0.033 DBMET02247 0.094 0.03 DBMET02255 | DBMET02255 | |
| 0.028 | 0.081 | 0.068 | Vanilloid 3 antagonist | 0.068 0.004 DBMET02245 0.041 0.021 DBMET02248 0.04 0.021 DBMET02251 | DBMET02245 | |
| 0.083 | 0.136 | 0.186 | Cyclooxygenase 3 inhibitor | 0.186 0.025 DBMET02245 0.158 0.042 DBMET02248 0.134 0.063 DBMET02250 0.171 0.033 DBMET02251 | DBMET02245 | |
| 0.038 | 0.091 | 0.094 | Sphingosine 1-phosphate receptor 3 antagonist | 0.067 0.029 DBMET02245 0.053 0.05 DBMET02244 0.053 0.05 DBMET02247 0.094 0.01 DBMET02248 0.059 0.04 DBMET02249 0.089 0.012 DBMET02251 | DBMET02248 | |
| 0.046 | 0.1 | 0.176 | Neuraminidase (influenza) inhibitor | 0.176 0.005 DBMET02245 0.077 0.027 DBMET02248 0.106 0.015 DBMET02249 | DBMET02245 | |
| 0.019 | 0.073 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.024 DBMET02245 | DBMET02245 | |
| 0.048 | 0.103 | 0.188 | Topoisomerase II alpha inhibitor | 0.073 0.058 DBMET02256 0.188 0.017 DBMET02245 | DBMET02245 | |
| 0.117 | 0.174 | 0.253 | Anticonvulsant | 0.253 0.056 DBMET02244 0.253 0.056 DBMET02247 0.207 0.077 DBMET02249 0.169 0.109 DBMET02251 | DBMET02247 | |
| 0.043 | 0.101 | 0.064 | Adenine nucleotide translocase inhibitor | 0.053 0.045 DBMET02242 0.054 0.044 DBMET02248 0.064 0.021 DBMET02251 | DBMET02251 | |
| 0.03 | 0.088 | 0.088 | Lysophosphatidic acid 3 receptor antagonist | 0.088 0.007 DBMET02245 0.062 0.02 DBMET02248 0.071 0.014 DBMET02250 0.077 0.011 DBMET02251 | DBMET02245 | |
| 0.17 | 0.229 | 0.284 | Apoptosis antagonist | 0.208 0.169 DBMET02256 0.207 0.171 DBMET02242 0.262 0.116 DBMET02245 0.278 0.102 DBMET02250 0.284 0.097 DBMET02251 | DBMET02251 | |
| 0.151 | 0.211 | 0.245 | 5 Hydroxytryptamine 3E antagonist | 0.182 0.1 DBMET02245 0.245 0.018 DBMET02244 0.245 0.018 DBMET02247 0.192 0.078 DBMET02248 0.17 0.136 DBMET02249 0.186 0.09 DBMET02255 0.164 0.157 DBMET02251 | DBMET02247 | |
| 0.019 | 0.079 | 0.039 | Estrogen-related receptor gamma antagonist | 0.037 0.007 DBMET02245 0.029 0.019 DBMET02244 0.029 0.019 DBMET02247 0.039 0.005 DBMET02248 0.033 0.01 DBMET02255 | DBMET02248 | |
| 0.15 | 0.212 | 0.238 | Transcription factor STAT3 inhibitor | 0.238 0.093 DBMET02245 0.18 0.165 DBMET02250 0.189 0.151 DBMET02251 | DBMET02245 | |
| 0.081 | 0.144 | 0.114 | Sodium channel (voltage-gated) blocker | 0.114 0.092 DBMET02245 | DBMET02245 | |
| 0.033 | 0.096 | 0.226 | Biliverdin reductase inhibitor | 0.072 0.031 DBMET02245 0.067 0.034 DBMET02244 0.067 0.034 DBMET02247 0.117 0.014 DBMET02248 0.101 0.018 DBMET02249 0.077 0.028 DBMET02250 0.226 0.005 DBMET02251 | DBMET02251 | |
| 0.117 | 0.181 | 0.386 | Platelet aggregation inhibitor | 0.335 0.029 DBMET02245 0.386 0.02 DBMET02250 | DBMET02250 | |
| 0.105 | 0.17 | 0.171 | Dual specificity phosphatase inhibitor | 0.133 0.116 DBMET02242 0.147 0.098 DBMET02255 0.171 0.074 DBMET02251 | DBMET02251 | |
| 0.016 | 0.081 | 0.116 | Phosphoglycerate kinase inhibitor | 0.116 0.006 DBMET02245 0.054 0.013 DBMET02248 0.031 0.03 DBMET02250 | DBMET02245 | |
| 0.041 | 0.107 | 0.148 | Carbonic anhydrase XIII inhibitor | 0.127 0.027 DBMET02245 0.086 0.046 DBMET02248 0.148 0.022 DBMET02251 | DBMET02251 | |
| 0.073 | 0.139 | 0.247 | MAP kinase kinase inhibitor | 0.247 0.016 DBMET02245 0.151 0.051 DBMET02248 0.161 0.046 DBMET02249 | DBMET02245 | |
| 0.12 | 0.186 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.162 0.021 DBMET02245 0.145 0.056 DBMET02244 0.145 0.056 DBMET02247 0.163 0.02 DBMET02248 0.143 0.063 DBMET02249 0.15 0.044 DBMET02250 0.14 0.073 DBMET02255 0.162 0.021 DBMET02251 | DBMET02248 | |
| 0.134 | 0.201 | 0.272 | DNA damaging | 0.244 0.084 DBMET02245 0.229 0.094 DBMET02248 0.272 0.069 DBMET02250 0.19 0.124 DBMET02252 0.162 0.155 DBMET02255 0.174 0.141 DBMET02251 | DBMET02250 | |
| 0.166 | 0.233 | 0.348 | Caspase 3 stimulant | 0.217 0.147 DBMET02256 0.348 0.06 DBMET02245 0.217 0.146 DBMET02250 | DBMET02245 | |
| 0.012 | 0.08 | 0.037 | Leukotriene A4 hydrolase inhibitor | 0.037 0.027 DBMET02250 | DBMET02250 | |
| 0.04 | 0.109 | 0.092 | Prostaglandin F2 alpha antagonist | 0.092 0.015 DBMET02245 0.069 0.034 DBMET02250 0.066 0.037 DBMET02251 | DBMET02245 | |
| 0.108 | 0.177 | 0.239 | Hepatoprotectant | 0.137 0.125 DBMET02256 0.239 0.046 DBMET02245 0.165 0.094 DBMET02250 | DBMET02245 | |
| 0.103 | 0.172 | 0.215 | Adenylate cyclase stimulant | 0.14 0.08 DBMET02242 0.215 0.008 DBMET02245 0.123 0.117 DBMET02244 0.123 0.117 DBMET02247 0.142 0.078 DBMET02248 0.128 0.105 DBMET02249 0.207 0.011 DBMET02250 0.136 0.089 DBMET02255 0.163 0.043 DBMET02251 | DBMET02245 | |
| 0.018 | 0.088 | 0.033 | Inosine monophosphate dehydrogenase inhibitor | 0.033 0.03 DBMET02251 | DBMET02251 | |
| 0.066 | 0.137 | 0.125 | Estrogen-related receptor beta agonist | 0.125 0.008 DBMET02245 0.119 0.01 DBMET02248 0.086 0.05 DBMET02250 0.096 0.03 DBMET02251 | DBMET02245 | |
| 0.105 | 0.177 | 0.214 | Interferon gamma antagonist | 0.214 0.036 DBMET02245 0.155 0.071 DBMET02248 0.142 0.089 DBMET02250 0.185 0.047 DBMET02251 | DBMET02245 | |
| 0.043 | 0.115 | 0.093 | Leukotriene C antagonist | 0.066 0.018 DBMET02245 0.064 0.021 DBMET02248 0.066 0.019 DBMET02250 0.093 0.005 DBMET02251 | DBMET02251 | |
| 0.036 | 0.108 | 0.055 | Vanilloid 2 antagonist | 0.055 0.03 DBMET02245 | DBMET02245 | |
| 0.031 | 0.104 | 0.105 | Alpha-mannosidase inhibitor | 0.105 0.006 DBMET02245 0.056 0.033 DBMET02248 0.067 0.019 DBMET02249 0.068 0.019 DBMET02250 0.05 0.043 DBMET02251 | DBMET02245 | |
| 0.009 | 0.082 | 0.037 | Cyclin E2 inhibitor | 0.037 0.014 DBMET02244 0.037 0.014 DBMET02247 | DBMET02247 | |
| 0.096 | 0.17 | 0.142 | Aurora-C kinase inhibitor | 0.142 0.062 DBMET02244 0.142 0.062 DBMET02247 0.124 0.097 DBMET02249 0.12 0.107 DBMET02255 | DBMET02247 | |
| 0.011 | 0.086 | 0.048 | Prostaglandin EP4 antagonist | 0.048 0.009 DBMET02251 | DBMET02251 | |
| 0.073 | 0.148 | 0.205 | Microtubule formation inhibitor | 0.205 0.019 DBMET02245 0.12 0.061 DBMET02248 0.122 0.058 DBMET02250 0.11 0.074 DBMET02251 | DBMET02245 | |
| 0.075 | 0.151 | 0.096 | Nav1.5 sodium channel blocker | 0.096 0.093 DBMET02250 | DBMET02250 | |
| 0.075 | 0.151 | 0.139 | Calcium channel N-type blocker | 0.139 0.045 DBMET02244 0.139 0.045 DBMET02247 | DBMET02247 | |
| 0.131 | 0.207 | 0.285 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.156 0.135 DBMET02256 0.266 0.036 DBMET02245 0.246 0.044 DBMET02248 0.163 0.121 DBMET02250 0.154 0.139 DBMET02255 0.285 0.028 DBMET02251 | DBMET02251 | |
| 0.019 | 0.097 | 0.106 | Glycine transporter 2 inhibitor | 0.065 0.023 DBMET02248 0.106 0.012 DBMET02251 | DBMET02251 | |
| 0.018 | 0.097 | 0.042 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.042 0.014 DBMET02245 0.032 0.027 DBMET02250 0.032 0.027 DBMET02251 | DBMET02245 | |
| 0.146 | 0.226 | 0.306 | Hypoxia-inducible factor 1 alpha inhibitor | 0.201 0.151 DBMET02256 0.306 0.063 DBMET02245 0.188 0.167 DBMET02250 0.197 0.156 DBMET02255 | DBMET02245 | |
| 0.028 | 0.11 | 0.154 | Neuraminidase inhibitor | 0.154 0.005 DBMET02245 0.069 0.035 DBMET02248 0.095 0.017 DBMET02249 | DBMET02245 | |
| 0.033 | 0.115 | 0.071 | Heparanase inhibitor | 0.056 0.031 DBMET02245 0.065 0.016 DBMET02248 0.071 0.011 DBMET02251 | DBMET02251 | |
| 0.05 | 0.133 | 0.369 | Keratolytic | 0.369 0.003 DBMET02245 0.09 0.038 DBMET02248 0.087 0.041 DBMET02250 0.099 0.031 DBMET02251 | DBMET02245 | |
| 0.119 | 0.203 | 0.193 | Catenin beta inhibitor | 0.161 0.083 DBMET02244 0.161 0.083 DBMET02247 0.154 0.097 DBMET02250 0.183 0.048 DBMET02255 0.193 0.038 DBMET02251 | DBMET02251 | |
| 0.059 | 0.143 | 0.348 | UDP-glucose 4-epimerase inhibitor | 0.091 0.072 DBMET02242 0.348 0.008 DBMET02245 0.161 0.025 DBMET02248 0.143 0.031 DBMET02249 0.11 0.051 DBMET02250 0.095 0.066 DBMET02255 0.118 0.045 DBMET02251 | DBMET02245 | |
| 0.095 | 0.179 | 0.297 | Growth hormone agonist | 0.162 0.078 DBMET02248 0.13 0.107 DBMET02255 0.297 0.033 DBMET02251 | DBMET02251 | |
| 0.019 | 0.105 | 0.047 | GABA uptake inhibitor | 0.042 0.023 DBMET02245 0.046 0.019 DBMET02248 0.047 0.018 DBMET02250 0.04 0.025 DBMET02251 | DBMET02250 | |
| 0.044 | 0.13 | 0.095 | Platelet activating factor beta antagonist | 0.095 0.066 DBMET02245 | DBMET02245 | |
| 0.036 | 0.122 | 0.074 | Sphingosine 1-phosphate receptor 5 agonist | 0.058 0.028 DBMET02245 0.074 0.015 DBMET02250 0.068 0.018 DBMET02251 | DBMET02250 | |
| 0.105 | 0.192 | 0.13 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.13 0.117 DBMET02244 0.13 0.117 DBMET02247 | DBMET02247 | |
| 0.076 | 0.165 | 0.154 | Factor V inhibitor | 0.154 0.016 DBMET02251 | DBMET02251 | |
| 0.023 | 0.112 | 0.104 | Prostaglandin EP2 antagonist | 0.075 0.029 DBMET02245 0.104 0.018 DBMET02250 0.073 0.031 DBMET02251 | DBMET02250 | |
| 0.004 | 0.095 | 0.029 | Ileal bile acid transport inhibitor | 0.029 0.005 DBMET02245 0.015 0.014 DBMET02248 0.025 0.006 DBMET02251 | DBMET02245 | |
| 0.156 | 0.247 | 0.479 | Immunosuppressant | 0.479 0.039 DBMET02245 0.302 0.114 DBMET02248 0.209 0.188 DBMET02249 0.253 0.145 DBMET02251 | DBMET02245 | |
| 0.021 | 0.112 | 0.102 | Mannosidase inhibitor | 0.102 0.005 DBMET02245 0.043 0.035 DBMET02248 0.054 0.022 DBMET02249 0.056 0.02 DBMET02250 0.041 0.039 DBMET02251 | DBMET02245 | |
| 0.043 | 0.135 | 0.069 | Ryanodine receptor antagonist | 0.069 0.019 DBMET02245 0.057 0.046 DBMET02244 0.057 0.046 DBMET02247 0.067 0.022 DBMET02250 0.06 0.038 DBMET02255 | DBMET02245 | |
| 0.055 | 0.147 | 0.134 | Platelet activating factor antagonist | 0.134 0.054 DBMET02245 | DBMET02245 | |
| 0.003 | 0.098 | 0.014 | Prostaglandin EP4 agonist | 0.014 0.011 DBMET02250 | DBMET02250 | |
| 0.014 | 0.112 | 0.039 | HMG CoA reductase inhibitor | 0.039 0.015 DBMET02245 0.033 0.027 DBMET02250 | DBMET02245 | |
| 0.033 | 0.131 | 0.056 | Sodium/calcium exchanger inhibitor | 0.056 0.024 DBMET02244 0.056 0.024 DBMET02247 0.048 0.04 DBMET02255 | DBMET02247 | |
| 0.017 | 0.117 | 0.031 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.018 DBMET02245 0.028 0.014 DBMET02248 0.031 0.01 DBMET02249 | DBMET02249 | |
| 0.01 | 0.11 | 0.026 | Caspase 8 inhibitor | 0.019 0.014 DBMET02248 0.026 0.007 DBMET02251 | DBMET02251 | |
| 0.008 | 0.109 | 0.031 | Renin inhibitor | 0.031 0.03 DBMET02245 | DBMET02245 | |
| 0.027 | 0.129 | 0.137 | Carbamoyl phosphate synthetase inhibitor | 0.137 0.013 DBMET02245 0.088 0.025 DBMET02248 0.08 0.028 DBMET02249 0.137 0.013 DBMET02250 0.12 0.015 DBMET02251 | DBMET02250 | |
| 0.029 | 0.132 | 0.091 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.054 0.047 DBMET02248 0.058 0.042 DBMET02250 0.091 0.02 DBMET02251 | DBMET02251 | |
| 0.018 | 0.121 | 0.044 | Estrogen-related receptor beta antagonist | 0.032 0.023 DBMET02245 0.044 0.008 DBMET02248 | DBMET02248 | |
| 0.05 | 0.153 | 0.192 | Bronchodilator | 0.085 0.08 DBMET02254 0.192 0.019 DBMET02245 0.11 0.053 DBMET02250 | DBMET02245 | |
| 0.065 | 0.168 | 0.145 | Lck kinase inhibitor | 0.145 0.068 DBMET02244 0.145 0.068 DBMET02247 | DBMET02247 | |
| 0.043 | 0.146 | 0.269 | GABA aminotransferase inhibitor | 0.07 0.061 DBMET02245 0.074 0.055 DBMET02244 0.074 0.055 DBMET02247 0.138 0.01 DBMET02248 0.269 0.004 DBMET02251 | DBMET02251 | |
| 0.027 | 0.13 | 0.119 | Glucose-6-phosphate isomerase inhibitor | 0.119 0.004 DBMET02245 0.073 0.011 DBMET02248 0.055 0.023 DBMET02249 0.064 0.016 DBMET02250 0.084 0.008 DBMET02251 | DBMET02245 | |
| 0.026 | 0.131 | 0.068 | Leukotriene C4 antagonist | 0.042 0.02 DBMET02245 0.043 0.019 DBMET02248 0.041 0.023 DBMET02250 0.068 0.004 DBMET02251 | DBMET02251 | |
| 0.076 | 0.182 | 0.516 | Peroxidase inhibitor | 0.117 0.103 DBMET02256 0.134 0.087 DBMET02242 0.516 0.008 DBMET02245 0.29 0.039 DBMET02248 0.127 0.093 DBMET02249 0.265 0.044 DBMET02250 0.116 0.105 DBMET02255 0.318 0.034 DBMET02251 | DBMET02245 | |
| 0.116 | 0.222 | 0.164 | Heat shock protein 70 antagonist | 0.145 0.058 DBMET02245 0.132 0.11 DBMET02244 0.132 0.11 DBMET02247 0.147 0.053 DBMET02248 0.135 0.098 DBMET02255 0.164 0.023 DBMET02251 | DBMET02251 | |
| 0.137 | 0.243 | 0.3 | Transcription factor NF kappa B inhibitor | 0.219 0.152 DBMET02256 0.3 0.094 DBMET02245 0.265 0.117 DBMET02248 0.231 0.142 DBMET02250 0.24 0.135 DBMET02251 | DBMET02245 | |
| 0.003 | 0.109 | 0.029 | Lysophosphatidic acid receptor 3 agonist | 0.029 0.004 DBMET02245 0.013 0.01 DBMET02248 | DBMET02245 | |
| 0.135 | 0.242 | 0.224 | RNA-directed DNA polymerase inhibitor | 0.167 0.159 DBMET02242 0.224 0.069 DBMET02245 0.222 0.072 DBMET02248 0.177 0.139 DBMET02250 0.216 0.078 DBMET02251 | DBMET02245 | |
| 0.119 | 0.227 | 0.167 | Growth factor agonist | 0.167 0.107 DBMET02248 0.153 0.134 DBMET02249 | DBMET02248 | |
| 0.012 | 0.12 | 0.039 | Lysophosphatidic acid receptor 1 agonist | 0.039 0.006 DBMET02245 0.031 0.01 DBMET02248 0.029 0.012 DBMET02251 | DBMET02245 | |
| 0.005 | 0.114 | 0.043 | Prostaglandin E2 agonist | 0.043 0.007 DBMET02245 | DBMET02245 | |
| 0.06 | 0.17 | 0.195 | Electrolyte absorption antagonist | 0.103 0.053 DBMET02245 0.086 0.083 DBMET02244 0.086 0.083 DBMET02247 0.13 0.029 DBMET02248 0.092 0.07 DBMET02249 0.087 0.08 DBMET02250 0.195 0.009 DBMET02251 | DBMET02251 | |
| 0.006 | 0.116 | 0.045 | Prostaglandin EP2 agonist | 0.045 0.007 DBMET02245 0.033 0.011 DBMET02251 | DBMET02245 | |
| 0.036 | 0.146 | 0.091 | Platelet growth factor antagonist | 0.091 0.047 DBMET02245 | DBMET02245 | |
| 0.064 | 0.174 | 0.098 | T cell inhibitor | 0.082 0.059 DBMET02244 0.082 0.059 DBMET02247 0.084 0.051 DBMET02248 0.098 0.026 DBMET02251 | DBMET02251 | |
| 0.052 | 0.163 | 0.113 | GABA B receptor agonist | 0.11 0.011 DBMET02245 0.095 0.02 DBMET02248 0.085 0.033 DBMET02250 0.113 0.01 DBMET02251 | DBMET02251 | |
| 0.028 | 0.14 | 0.125 | Phosphodiesterase III inhibitor | 0.125 0.014 DBMET02245 | DBMET02245 | |
| 0.009 | 0.121 | 0.027 | Antibiotic Anthracycline-like | 0.027 0.004 DBMET02245 | DBMET02245 | |
| 0.08 | 0.192 | 0.175 | Psychostimulant | 0.158 0.109 DBMET02245 0.174 0.097 DBMET02244 0.174 0.097 DBMET02247 0.175 0.096 DBMET02250 0.14 0.125 DBMET02251 | DBMET02250 | |
| 0.021 | 0.135 | 0.071 | Neuraminidase (Influenza A) inhibitor | 0.071 0.007 DBMET02245 0.053 0.02 DBMET02248 0.046 0.03 DBMET02249 | DBMET02245 | |
| 0.032 | 0.148 | 0.068 | 5 Hydroxytryptamine 7 agonist | 0.068 0.021 DBMET02244 0.068 0.021 DBMET02247 0.055 0.041 DBMET02255 | DBMET02247 | |
| 0.007 | 0.125 | 0.071 | Uridine phosphorylase inhibitor | 0.071 0.004 DBMET02245 0.038 0.013 DBMET02248 0.026 0.022 DBMET02251 | DBMET02245 | |
| 0.022 | 0.141 | 0.359 | Alcohol oxidase inhibitor | 0.359 0.004 DBMET02245 0.118 0.014 DBMET02248 0.05 0.045 DBMET02249 0.118 0.014 DBMET02250 0.13 0.013 DBMET02251 | DBMET02245 | |
| 0.009 | 0.128 | 0.08 | Prostaglandin agonist | 0.08 0.006 DBMET02245 0.03 0.023 DBMET02250 0.028 0.025 DBMET02251 | DBMET02245 | |
| 0.03 | 0.15 | 0.097 | Epithelial sodium channel blocker | 0.097 0.008 DBMET02245 | DBMET02245 | |
| 0.061 | 0.182 | 0.207 | Bone formation stimulant | 0.207 0.034 DBMET02245 0.11 0.095 DBMET02248 0.145 0.063 DBMET02250 0.147 0.061 DBMET02251 | DBMET02245 | |
| 0.053 | 0.174 | 0.21 | Chelator | 0.1 0.078 DBMET02242 0.118 0.055 DBMET02245 0.21 0.023 DBMET02250 0.11 0.065 DBMET02255 | DBMET02250 | |
| 0.029 | 0.151 | 0.055 | CC chemokine receptor 2B antagonist | 0.047 0.037 DBMET02244 0.047 0.037 DBMET02247 0.055 0.023 DBMET02251 | DBMET02251 | |
| 0.022 | 0.145 | 0.069 | 5 Hydroxytryptamine 7 antagonist | 0.069 0.038 DBMET02244 0.069 0.038 DBMET02247 | DBMET02247 | |
| 0.022 | 0.147 | 0.052 | Thymidine kinase inhibitor | 0.037 0.035 DBMET02245 0.05 0.019 DBMET02248 0.052 0.017 DBMET02249 0.038 0.034 DBMET02250 | DBMET02249 | |
| 0.021 | 0.148 | 0.047 | 5 Hydroxytryptamine 4 antagonist | 0.047 0.045 DBMET02250 | DBMET02250 | |
| 0.125 | 0.254 | 0.272 | Thioredoxin glutathione reductase inhibitor | 0.272 0.12 DBMET02248 | DBMET02248 | |
| 0.03 | 0.161 | 0.043 | Heme oxygenase inhibitor | 0.043 0.03 DBMET02245 | DBMET02245 | |
| 0.038 | 0.17 | 0.117 | Telomerase inhibitor | 0.117 0.027 DBMET02244 0.117 0.027 DBMET02247 0.084 0.042 DBMET02248 0.081 0.044 DBMET02255 0.074 0.048 DBMET02251 | DBMET02247 | |
| 0.007 | 0.14 | 0.022 | Estrogen-related receptor gamma agonist | 0.022 0.007 DBMET02248 | DBMET02248 | |
| 0.059 | 0.192 | 0.177 | Caspase 3 inhibitor | 0.161 0.021 DBMET02248 0.177 0.015 DBMET02251 | DBMET02251 | |
| 0.004 | 0.139 | 0.027 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.027 0.02 DBMET02245 0.027 0.02 DBMET02249 | DBMET02249 | |
| 0.016 | 0.152 | 0.034 | Hedgehog signaling activator | 0.034 0.008 DBMET02245 | DBMET02245 | |
| 0.048 | 0.184 | 0.13 | Glutathione S-transferase inhibitor | 0.098 0.039 DBMET02245 0.125 0.02 DBMET02248 0.13 0.018 DBMET02251 | DBMET02251 | |
| 0.091 | 0.227 | 0.193 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.171 0.12 DBMET02244 0.171 0.12 DBMET02247 0.183 0.111 DBMET02248 0.193 0.104 DBMET02255 0.189 0.107 DBMET02251 | DBMET02255 | |
| 0.055 | 0.192 | 0.172 | Alkylator | 0.172 0.036 DBMET02245 0.139 0.053 DBMET02248 0.147 0.048 DBMET02250 0.113 0.075 DBMET02251 | DBMET02245 | |
| 0.047 | 0.183 | 0.131 | Cell adhesion molecule inhibitor | 0.131 0.02 DBMET02251 | DBMET02251 | |
| 0.08 | 0.216 | 0.281 | Mannose-6-phosphate isomerase inhibitor | 0.281 0.007 DBMET02245 0.169 0.05 DBMET02248 0.121 0.099 DBMET02250 0.188 0.038 DBMET02251 | DBMET02245 | |
| 0.009 | 0.148 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.021 0.014 DBMET02245 0.022 0.012 DBMET02248 0.021 0.015 DBMET02251 | DBMET02248 | |
| 0.024 | 0.164 | 0.069 | Leukotriene B4 antagonist | 0.069 0.02 DBMET02245 | DBMET02245 | |
| 0.024 | 0.164 | 0.117 | Leukotriene antagonist | 0.117 0.016 DBMET02245 0.078 0.033 DBMET02250 0.09 0.026 DBMET02251 | DBMET02245 | |
| 0.01 | 0.15 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.01 DBMET02251 | DBMET02251 | |
| 0.147 | 0.287 | 0.29 | Transcription factor inhibitor | 0.29 0.16 DBMET02248 0.219 0.21 DBMET02251 | DBMET02248 | |
| 0.088 | 0.228 | 0.265 | Melanin inhibitor | 0.265 0.026 DBMET02245 0.134 0.107 DBMET02248 0.131 0.112 DBMET02250 0.145 0.089 DBMET02251 | DBMET02245 | |
| 0.056 | 0.197 | 0.095 | D-Ala-D-Ala ligase inhibitor | 0.083 0.059 DBMET02245 0.08 0.068 DBMET02248 0.084 0.058 DBMET02255 0.095 0.036 DBMET02251 | DBMET02251 | |
| 0.063 | 0.204 | 0.123 | Src kinase inhibitor | 0.123 0.105 DBMET02244 0.123 0.105 DBMET02247 | DBMET02247 | |
| 0.009 | 0.151 | 0.031 | Prostaglandin D2 agonist | 0.031 0.02 DBMET02245 0.027 0.026 DBMET02250 | DBMET02245 | |
| 0.036 | 0.182 | 0.076 | Interferon inducer | 0.064 0.044 DBMET02245 0.06 0.053 DBMET02244 0.06 0.053 DBMET02247 0.07 0.035 DBMET02248 0.076 0.028 DBMET02250 | DBMET02250 | |
| 0.083 | 0.229 | 0.178 | Nitric oxide antagonist | 0.178 0.078 DBMET02245 0.126 0.125 DBMET02250 | DBMET02245 | |
| 0.022 | 0.168 | 0.082 | Selectin antagonist | 0.082 0.036 DBMET02245 | DBMET02245 | |
| 0.027 | 0.173 | 0.157 | Histidine decarboxylase inhibitor | 0.157 0.018 DBMET02245 0.1 0.032 DBMET02250 0.099 0.032 DBMET02251 | DBMET02245 | |
| 0.03 | 0.176 | 0.088 | Sphingosine 1-phosphate receptor 1 antagonist | 0.059 0.03 DBMET02245 0.064 0.023 DBMET02248 0.088 0.012 DBMET02251 | DBMET02251 | |
| 0.01 | 0.157 | 0.05 | Calcium-sensing receptor agonist | 0.05 0.005 DBMET02251 | DBMET02251 | |
| 0.096 | 0.243 | 0.413 | Tumour necrosis factor alpha release inhibitor | 0.413 0.025 DBMET02245 | DBMET02245 | |
| 0.094 | 0.241 | 0.165 | 3C-like protease (Human coronavirus) inhibitor | 0.16 0.086 DBMET02245 0.165 0.08 DBMET02244 0.165 0.08 DBMET02247 0.135 0.131 DBMET02248 | DBMET02247 | |
| 0.067 | 0.214 | 0.246 | Interleukin 4 antagonist | 0.11 0.101 DBMET02256 0.246 0.014 DBMET02245 | DBMET02245 | |
| 0.03 | 0.179 | 0.051 | Alpha 1b adrenoreceptor agonist | 0.051 0.034 DBMET02244 0.051 0.034 DBMET02247 | DBMET02247 | |
| 0.023 | 0.173 | 0.061 | Aminopeptidase microsomal inhibitor | 0.061 0.038 DBMET02251 | DBMET02251 | |
| 0.038 | 0.188 | 0.1 | Interferon agonist | 0.096 0.033 DBMET02245 0.088 0.041 DBMET02248 0.076 0.058 DBMET02249 0.1 0.028 DBMET02250 0.073 0.065 DBMET02251 | DBMET02250 | |
| 0.09 | 0.241 | 0.323 | Immunostimulant | 0.323 0.072 DBMET02245 0.314 0.075 DBMET02248 0.199 0.121 DBMET02249 0.195 0.123 DBMET02250 0.294 0.08 DBMET02251 | DBMET02245 | |
| 0.031 | 0.182 | 0.112 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.112 0.032 DBMET02245 | DBMET02245 | |
| 0.034 | 0.186 | 0.103 | ALK inhibitor | 0.103 0.039 DBMET02245 | DBMET02245 | |
| 0.015 | 0.168 | 0.044 | Aminopeptidase N inhibitor | 0.044 0.038 DBMET02251 | DBMET02251 | |
| 0.018 | 0.171 | 0.088 | Acyl-CoA dehydrogenase inhibitor | 0.082 0.021 DBMET02245 0.071 0.026 DBMET02248 0.056 0.036 DBMET02250 0.088 0.019 DBMET02251 | DBMET02251 | |
| 0.073 | 0.226 | 0.241 | Phospholipase A2 inhibitor | 0.241 0.026 DBMET02245 0.16 0.066 DBMET02248 0.155 0.069 DBMET02250 0.17 0.06 DBMET02251 | DBMET02245 | |
| 0.083 | 0.236 | 0.126 | Hemostatic | 0.124 0.106 DBMET02244 0.124 0.106 DBMET02247 0.125 0.105 DBMET02249 0.126 0.102 DBMET02251 | DBMET02251 | |
| 0.008 | 0.162 | 0.046 | Peroxisome proliferator-activated receptor delta agonist | 0.036 0.02 DBMET02245 0.046 0.014 DBMET02250 | DBMET02250 | |
| 0.069 | 0.223 | 0.243 | Protein kinase stimulant | 0.243 0.028 DBMET02245 0.239 0.029 DBMET02248 0.182 0.049 DBMET02251 | DBMET02245 | |
| 0.009 | 0.165 | 0.048 | Sodium/glucose cotransporter inhibitor | 0.048 0.005 DBMET02245 | DBMET02245 | |
| 0.009 | 0.164 | 0.059 | Prostaglandin F2 alpha agonist | 0.059 0.004 DBMET02245 0.023 0.015 DBMET02250 | DBMET02245 | |
| 0.134 | 0.291 | 0.333 | Insulysin inhibitor | 0.215 0.135 DBMET02245 0.223 0.125 DBMET02244 0.223 0.125 DBMET02247 0.238 0.108 DBMET02248 0.201 0.156 DBMET02255 0.333 0.041 DBMET02251 | DBMET02251 | |
| 0.055 | 0.212 | 0.088 | Vanilloid agonist | 0.082 0.066 DBMET02245 0.088 0.05 DBMET02248 | DBMET02248 | |
| 0.026 | 0.182 | 0.092 | Histamine H1 receptor antagonist | 0.092 0.047 DBMET02250 | DBMET02250 | |
| 0.062 | 0.218 | 0.115 | Estrogen antagonist | 0.115 0.065 DBMET02256 0.115 0.064 DBMET02255 | DBMET02255 | |
| 0.064 | 0.222 | 0.197 | Cell adhesion inhibitor | 0.099 0.091 DBMET02250 0.197 0.025 DBMET02251 | DBMET02251 | |
| 0.043 | 0.201 | 0.129 | Topoisomerase II inhibitor | 0.129 0.061 DBMET02245 0.121 0.066 DBMET02250 | DBMET02245 | |
| 0.007 | 0.165 | 0.067 | Sodium/glucose cotransporter 2 inhibitor | 0.067 0.005 DBMET02245 | DBMET02245 | |
| 0.057 | 0.216 | 0.152 | Toll-Like receptor 9 antagonist | 0.152 0.062 DBMET02244 0.152 0.062 DBMET02247 | DBMET02247 | |
| 0.064 | 0.223 | 0.148 | Antibacterial (Helicobacter pylori) | 0.148 0.047 DBMET02245 0.118 0.084 DBMET02250 | DBMET02245 | |
| 0.138 | 0.297 | 0.392 | Tyrosine 3 hydroxylase inhibitor | 0.181 0.173 DBMET02242 0.265 0.055 DBMET02245 0.231 0.089 DBMET02244 0.231 0.089 DBMET02247 0.28 0.044 DBMET02248 0.251 0.067 DBMET02250 0.238 0.08 DBMET02255 0.392 0.009 DBMET02251 | DBMET02251 | |
| 0.049 | 0.209 | 0.108 | Estrogen receptor beta antagonist | 0.103 0.058 DBMET02256 0.108 0.05 DBMET02255 | DBMET02255 | |
| 0.009 | 0.169 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.018 DBMET02248 0.022 0.011 DBMET02249 | DBMET02249 | |
| 0.008 | 0.168 | 0.023 | Lysophosphatidic acid 1 receptor antagonist | 0.023 0.012 DBMET02245 0.021 0.015 DBMET02251 | DBMET02245 | |
| 0.03 | 0.19 | 0.147 | Aminopeptidase I inhibitor | 0.098 0.029 DBMET02245 0.112 0.022 DBMET02248 0.08 0.042 DBMET02249 0.072 0.051 DBMET02250 0.147 0.013 DBMET02251 | DBMET02251 | |
| 0.019 | 0.179 | 0.064 | 5 Hydroxytryptamine 1D antagonist | 0.064 0.045 DBMET02244 0.064 0.045 DBMET02247 | DBMET02247 | |
| 0.009 | 0.17 | 0.036 | Carnitine palmitoyltransferase 1 inhibitor | 0.036 0.02 DBMET02250 | DBMET02250 | |
| 0.051 | 0.213 | 0.119 | Proteasome inhibitor | 0.119 0.066 DBMET02248 | DBMET02248 | |
| 0.079 | 0.241 | 0.127 | DNA repair enzyme inhibitor | 0.113 0.087 DBMET02245 0.112 0.089 DBMET02244 0.112 0.089 DBMET02247 0.107 0.106 DBMET02250 0.127 0.059 DBMET02251 | DBMET02251 | |
| 0.009 | 0.171 | 0.037 | Caspase 2 inhibitor | 0.037 0.018 DBMET02251 | DBMET02251 | |
| 0.006 | 0.17 | 0.013 | Cyclin D2 inhibitor | 0.013 0.01 DBMET02244 0.013 0.01 DBMET02247 | DBMET02247 | |
| 0.041 | 0.205 | 0.124 | Sphingosine 1-phosphate receptor antagonist | 0.073 0.061 DBMET02245 0.098 0.023 DBMET02248 0.124 0.011 DBMET02251 | DBMET02251 | |
| 0.07 | 0.235 | 0.187 | Cell wall synthesis inhibitor | 0.169 0.048 DBMET02245 0.113 0.111 DBMET02248 0.165 0.051 DBMET02249 0.144 0.071 DBMET02250 0.187 0.036 DBMET02251 | DBMET02251 | |
| 0.047 | 0.212 | 0.267 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.231 0.012 DBMET02245 0.151 0.026 DBMET02248 0.1 0.054 DBMET02249 0.099 0.055 DBMET02250 0.267 0.008 DBMET02251 | DBMET02251 | |
| 0.009 | 0.174 | 0.036 | Carnitine palmitoyltransferase inhibitor | 0.036 0.021 DBMET02250 | DBMET02250 | |
| 0.015 | 0.181 | 0.067 | Adenosine deaminase inhibitor | 0.067 0.015 DBMET02245 0.061 0.019 DBMET02248 0.041 0.039 DBMET02249 0.046 0.035 DBMET02251 | DBMET02245 | |
| 0.058 | 0.225 | 0.116 | CC chemokine 5 receptor agonist | 0.116 0.01 DBMET02244 0.116 0.01 DBMET02247 0.091 0.035 DBMET02248 0.104 0.018 DBMET02255 0.092 0.033 DBMET02251 | DBMET02247 | |
| 0.009 | 0.177 | 0.067 | Fumarate hydratase inhibitor | 0.047 0.014 DBMET02245 0.038 0.02 DBMET02250 0.067 0.009 DBMET02251 | DBMET02251 | |
| 0.029 | 0.2 | 0.084 | Potassium channel (ATP-sensitive) blocker | 0.084 0.025 DBMET02248 | DBMET02248 | |
| 0.045 | 0.215 | 0.127 | Alpha 2b adrenoreceptor antagonist | 0.127 0.053 DBMET02244 0.127 0.053 DBMET02247 0.099 0.075 DBMET02255 | DBMET02247 | |
| 0.054 | 0.225 | 0.128 | Carbonic anhydrase XV inhibitor | 0.128 0.041 DBMET02245 0.122 0.045 DBMET02248 0.102 0.065 DBMET02251 | DBMET02245 | |
| 0.01 | 0.182 | 0.066 | Peroxisome proliferator-activated receptor alpha agonist | 0.066 0.024 DBMET02245 0.062 0.025 DBMET02250 | DBMET02245 | |
| 0.007 | 0.179 | 0.025 | 5-Alpha-reductase 2 inhibitor | 0.025 0.01 DBMET02251 | DBMET02251 | |
| 0.014 | 0.187 | 0.034 | Ceramide glucosyltransferase inhibitor | 0.034 0.028 DBMET02248 | DBMET02248 | |
| 0.034 | 0.206 | 0.065 | Secretase beta inhibitor | 0.065 0.06 DBMET02245 | DBMET02245 | |
| 0.031 | 0.205 | 0.083 | Ca(v)3.2 blocker | 0.083 0.013 DBMET02244 0.083 0.013 DBMET02247 0.068 0.024 DBMET02255 | DBMET02247 | |
| 0.048 | 0.224 | 0.22 | DNA polymerase I inhibitor | 0.22 0.023 DBMET02245 0.164 0.042 DBMET02248 0.121 0.068 DBMET02251 | DBMET02245 | |
| 0.019 | 0.196 | 0.092 | Purinergic P2X2 antagonist | 0.092 0.034 DBMET02245 | DBMET02245 | |
| 0.014 | 0.191 | 0.05 | Alpha tubulin antagonist | 0.05 0.041 DBMET02245 | DBMET02245 | |
| 0.096 | 0.273 | 0.231 | Phospholipase C inhibitor | 0.191 0.05 DBMET02245 0.155 0.097 DBMET02244 0.155 0.097 DBMET02247 0.199 0.045 DBMET02248 0.138 0.132 DBMET02249 0.146 0.114 DBMET02250 0.17 0.073 DBMET02255 0.231 0.029 DBMET02251 | DBMET02251 | |
| 0.024 | 0.203 | 0.065 | Squalene epoxidase inhibitor | 0.065 0.017 DBMET02245 | DBMET02245 | |
| 0.047 | 0.227 | 0.084 | Polo-like kinase-1 inhibitor | 0.084 0.074 DBMET02245 | DBMET02245 | |
| 0.044 | 0.224 | 0.176 | Tubulin antagonist | 0.176 0.046 DBMET02245 | DBMET02245 | |
| 0.002 | 0.183 | 0.01 | Thromboxane agonist | 0.01 0.009 DBMET02245 0.01 0.009 DBMET02251 | DBMET02251 | |
| 0.03 | 0.212 | 0.071 | DNA helicase inhibitor | 0.071 0.017 DBMET02251 | DBMET02251 | |
| 0.063 | 0.245 | 0.148 | Acetylcholine M1 receptor antagonist | 0.148 0.076 DBMET02244 0.148 0.076 DBMET02247 0.116 0.114 DBMET02255 | DBMET02247 | |
| 0.023 | 0.205 | 0.072 | Cyclin D1 inhibitor | 0.072 0.026 DBMET02244 0.072 0.026 DBMET02247 0.061 0.04 DBMET02255 | DBMET02247 | |
| 0.016 | 0.2 | 0.05 | Sphingosine kinase 1 inhibitor | 0.045 0.023 DBMET02245 0.05 0.016 DBMET02248 0.039 0.033 DBMET02249 | DBMET02248 | |
| 0.006 | 0.19 | 0.021 | Integrin beta5 antagonist | 0.021 0.014 DBMET02251 | DBMET02251 | |
| 0.03 | 0.216 | 0.413 | Histone deacetylase SIRT1 stimulant | 0.413 0.004 DBMET02245 | DBMET02245 | |
| 0.03 | 0.216 | 0.413 | Histone deacetylase stimulant | 0.413 0.004 DBMET02245 | DBMET02245 | |
| 0.044 | 0.23 | 0.15 | Interleukin 1 beta converting enzyme inhibitor | 0.103 0.054 DBMET02244 0.103 0.054 DBMET02247 0.117 0.038 DBMET02248 0.087 0.078 DBMET02255 0.15 0.017 DBMET02251 | DBMET02251 | |
| 0.157 | 0.344 | 0.344 | Apoptosis agonist | 0.271 0.194 DBMET02254 0.24 0.226 DBMET02256 0.344 0.142 DBMET02245 | DBMET02245 | |
| 0.036 | 0.224 | 0.06 | Immunoglobulin Fc receptor antagonist | 0.06 0.025 DBMET02245 0.055 0.038 DBMET02248 | DBMET02245 | |
| 0.009 | 0.199 | 0.056 | Beta tubulin antagonist | 0.056 0.042 DBMET02245 | DBMET02245 | |
| 0.017 | 0.208 | 0.069 | 5 Hydroxytryptamine 1F antagonist | 0.069 0.05 DBMET02244 0.069 0.05 DBMET02247 | DBMET02247 | |
| 0.045 | 0.238 | 0.13 | Beta glucuronidase inhibitor | 0.092 0.083 DBMET02245 0.104 0.064 DBMET02244 0.104 0.064 DBMET02247 0.13 0.037 DBMET02255 | DBMET02255 | |
| 0.015 | 0.209 | 0.035 | Melatonin receptor 1A agonist | 0.035 0.02 DBMET02245 | DBMET02245 | |
| 0.011 | 0.206 | 0.033 | Peroxisome proliferator-activated receptor delta antagonist | 0.033 0.024 DBMET02250 | DBMET02250 | |
| 0.009 | 0.204 | 0.073 | Guanylate cyclase inhibitor | 0.073 0.004 DBMET02245 | DBMET02245 | |
| 0.027 | 0.222 | 0.207 | Monophenol monooxygenase inhibitor | 0.207 0.032 DBMET02245 0.104 0.073 DBMET02251 | DBMET02245 | |
| 0.115 | 0.31 | 0.194 | Transcription factor STAT inhibitor | 0.194 0.147 DBMET02245 0.176 0.175 DBMET02255 | DBMET02245 | |
| 0.035 | 0.232 | 0.169 | Carbonic anhydrase VI inhibitor | 0.091 0.046 DBMET02245 0.1 0.039 DBMET02248 0.169 0.017 DBMET02251 | DBMET02251 | |
| 0.049 | 0.245 | 0.083 | Transcription factor NF kappa B stimulant | 0.083 0.062 DBMET02251 | DBMET02251 | |
| 0.016 | 0.212 | 0.05 | Potassium channel (Inward rectifier) blocker | 0.05 0.034 DBMET02244 0.05 0.034 DBMET02247 | DBMET02247 | |
| 0.048 | 0.246 | 0.131 | Granulocyte macrophage colony stimulating factor agonist | 0.131 0.01 DBMET02245 0.085 0.062 DBMET02248 0.083 0.067 DBMET02250 0.086 0.06 DBMET02251 | DBMET02245 | |
| 0.082 | 0.281 | 0.148 | MAP kinase 3 inhibitor | 0.128 0.113 DBMET02245 0.148 0.071 DBMET02248 0.129 0.109 DBMET02249 | DBMET02248 | |
| 0.053 | 0.253 | 0.111 | Alpha 2d adrenoreceptor antagonist | 0.111 0.033 DBMET02244 0.111 0.033 DBMET02247 0.089 0.074 DBMET02255 | DBMET02247 | |
| 0.023 | 0.223 | 0.074 | Sphingosine kinase inhibitor | 0.071 0.023 DBMET02245 0.074 0.021 DBMET02248 0.057 0.045 DBMET02249 | DBMET02248 | |
| 0.028 | 0.228 | 0.062 | Pregnane X receptor antagonist | 0.062 0.026 DBMET02245 0.053 0.051 DBMET02248 0.058 0.035 DBMET02251 | DBMET02245 | |
| 0.016 | 0.217 | 0.094 | Peroxisome proliferator-activated receptor gamma agonist | 0.06 0.058 DBMET02245 0.094 0.032 DBMET02250 | DBMET02250 | |
| 0.019 | 0.221 | 0.147 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.147 0.009 DBMET02245 0.063 0.031 DBMET02248 0.06 0.035 DBMET02249 0.052 0.045 DBMET02250 0.053 0.043 DBMET02251 | DBMET02245 | |
| 0.037 | 0.239 | 0.144 | Creatine kinase inhibitor | 0.094 0.066 DBMET02242 0.126 0.037 DBMET02245 0.1 0.06 DBMET02244 0.1 0.06 DBMET02247 0.144 0.026 DBMET02248 0.093 0.068 DBMET02249 0.099 0.061 DBMET02250 0.125 0.038 DBMET02255 0.137 0.03 DBMET02251 | DBMET02248 | |
| 0.098 | 0.301 | 0.192 | Neurotensin receptor agonist | 0.144 0.117 DBMET02245 0.142 0.124 DBMET02244 0.142 0.124 DBMET02247 0.165 0.07 DBMET02248 0.14 0.13 DBMET02255 0.192 0.039 DBMET02251 | DBMET02251 | |
| 0.045 | 0.251 | 0.265 | Carbonic anhydrase III inhibitor | 0.128 0.039 DBMET02245 0.16 0.025 DBMET02248 0.265 0.008 DBMET02251 | DBMET02251 | |
| 0.026 | 0.232 | 0.095 | Dihydroorotate oxidase inhibitor | 0.059 0.031 DBMET02244 0.059 0.031 DBMET02247 0.094 0.006 DBMET02248 0.061 0.027 DBMET02255 0.095 0.005 DBMET02251 | DBMET02251 | |
| 0.015 | 0.221 | 0.044 | Cholecystokinin B agonist | 0.044 0.02 DBMET02251 | DBMET02251 | |
| 0.003 | 0.211 | 0.02 | 5-Alpha-reductase 1 inhibitor | 0.02 0.011 DBMET02251 | DBMET02251 | |
| 0.011 | 0.219 | 0.036 | Toll-Like receptor 2 agonist | 0.036 0.034 DBMET02245 0.036 0.033 DBMET02251 | DBMET02251 | |
| 0.02 | 0.229 | 0.128 | Carbonic anhydrase VA inhibitor | 0.074 0.041 DBMET02248 0.128 0.016 DBMET02251 | DBMET02251 | |
| 0.041 | 0.25 | 0.083 | Protein kinase C zeta inhibitor | 0.083 0.08 DBMET02245 | DBMET02245 | |
| 0.038 | 0.248 | 0.182 | Cystathionine beta-synthase inhibitor | 0.16 0.036 DBMET02245 0.121 0.057 DBMET02248 0.104 0.072 DBMET02250 0.09 0.089 DBMET02255 0.182 0.029 DBMET02251 | DBMET02251 | |
| 0.006 | 0.216 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.028 0.007 DBMET02245 | DBMET02245 | |
| 0.04 | 0.252 | 0.106 | Alpha 2c adrenoreceptor antagonist | 0.106 0.061 DBMET02244 0.106 0.061 DBMET02247 | DBMET02247 | |
| 0.055 | 0.267 | 0.168 | Adenylate kinase inhibitor | 0.154 0.025 DBMET02245 0.11 0.053 DBMET02248 0.128 0.037 DBMET02250 0.168 0.021 DBMET02251 | DBMET02251 | |
| 0.013 | 0.226 | 0.067 | Carbonic anhydrase XIV inhibitor | 0.067 0.021 DBMET02251 | DBMET02251 | |
| 0.068 | 0.282 | 0.287 | Interleukin antagonist | 0.287 0.051 DBMET02245 0.137 0.129 DBMET02248 0.146 0.121 DBMET02251 | DBMET02245 | |
| 0.003 | 0.217 | 0.046 | Carbonic anhydrase X inhibitor | 0.019 0.009 DBMET02248 0.046 0.003 DBMET02251 | DBMET02251 | |
| 0.003 | 0.217 | 0.046 | Carbonic anhydrase VIII inhibitor | 0.019 0.009 DBMET02248 0.046 0.003 DBMET02251 | DBMET02251 | |
| 0.082 | 0.298 | 0.246 | Calpain inhibitor | 0.246 0.068 DBMET02248 0.221 0.093 DBMET02251 | DBMET02248 | |
| 0.008 | 0.225 | 0.047 | Dihydropteroate synthase inhibitor | 0.036 0.033 DBMET02248 0.047 0.02 DBMET02251 | DBMET02251 | |
| 0.021 | 0.24 | 0.053 | Acetyl-CoA transferase 2 inhibitor | 0.053 0.05 DBMET02248 0.052 0.051 DBMET02251 | DBMET02248 | |
| 0.009 | 0.228 | 0.048 | Phosphodiesterase 3B inhibitor | 0.048 0.027 DBMET02245 | DBMET02245 | |
| 0.005 | 0.224 | 0.024 | Retinoid X gamma receptor agonist | 0.024 0.015 DBMET02251 | DBMET02251 | |
| 0.004 | 0.223 | 0.032 | Cholecystokinin B antagonist | 0.032 0.02 DBMET02251 | DBMET02251 | |
| 0.027 | 0.247 | 0.104 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.1 0.01 DBMET02244 0.1 0.01 DBMET02247 0.104 0.009 DBMET02255 | DBMET02255 | |
| 0.005 | 0.225 | 0.066 | Carbonic anhydrase IV inhibitor | 0.066 0.017 DBMET02251 | DBMET02251 | |
| 0.011 | 0.231 | 0.03 | Caspase 6 inhibitor | 0.03 0.022 DBMET02251 | DBMET02251 | |
| 0.067 | 0.288 | 0.327 | MAP kinase kinase 2 inhibitor | 0.327 0.027 DBMET02245 0.178 0.097 DBMET02248 0.136 0.135 DBMET02249 | DBMET02245 | |
| 0.034 | 0.255 | 0.125 | Glycine receptor agonist | 0.087 0.031 DBMET02245 0.098 0.022 DBMET02248 0.091 0.027 DBMET02250 0.125 0.011 DBMET02251 | DBMET02251 | |
| 0.017 | 0.238 | 0.136 | Carbonic anhydrase V inhibitor | 0.069 0.044 DBMET02248 0.136 0.018 DBMET02251 | DBMET02251 | |
| 0.019 | 0.241 | 0.28 | Phenylalanine 4-hydroxylase inhibitor | 0.28 0.004 DBMET02245 0.099 0.026 DBMET02248 0.08 0.037 DBMET02249 0.074 0.043 DBMET02250 0.142 0.013 DBMET02251 | DBMET02245 | |
| 0.086 | 0.308 | 0.294 | 5 Hydroxytryptamine 1E antagonist | 0.294 0.034 DBMET02244 0.294 0.034 DBMET02247 0.169 0.167 DBMET02248 0.245 0.08 DBMET02255 | DBMET02247 | |
| 0.012 | 0.233 | 0.055 | Acetylcholine M3 receptor antagonist | 0.055 0.048 DBMET02244 0.055 0.048 DBMET02247 0.053 0.051 DBMET02255 | DBMET02247 | |
| 0.018 | 0.241 | 0.124 | Aconitate hydratase inhibitor | 0.1 0.008 DBMET02245 0.061 0.025 DBMET02248 0.066 0.021 DBMET02250 0.124 0.005 DBMET02251 | DBMET02251 | |
| 0.01 | 0.235 | 0.11 | Delayed rectifier potassium channel activator | 0.035 0.027 DBMET02244 0.035 0.027 DBMET02247 0.11 0.004 DBMET02248 0.043 0.02 DBMET02251 | DBMET02248 | |
| 0.01 | 0.235 | 0.11 | Potassium channel KCNQ activator | 0.035 0.027 DBMET02244 0.035 0.027 DBMET02247 0.11 0.004 DBMET02248 0.043 0.02 DBMET02251 | DBMET02248 | |
| 0.058 | 0.283 | 0.181 | Diuretic | 0.181 0.053 DBMET02245 0.119 0.106 DBMET02249 0.179 0.055 DBMET02250 0.149 0.078 DBMET02251 | DBMET02245 | |
| 0.033 | 0.257 | 0.077 | Caspase 9 inhibitor | 0.077 0.025 DBMET02251 | DBMET02251 | |
| 0.009 | 0.234 | 0.102 | Carbonic anhydrase VB inhibitor | 0.066 0.03 DBMET02248 0.102 0.015 DBMET02251 | DBMET02251 | |
| 0.07 | 0.295 | 0.364 | Platelet antagonist | 0.164 0.131 DBMET02245 0.364 0.035 DBMET02250 0.322 0.046 DBMET02251 | DBMET02250 | |
| 0.022 | 0.25 | 0.136 | Androgen antagonist | 0.136 0.027 DBMET02245 0.083 0.062 DBMET02248 | DBMET02245 | |
| 0.037 | 0.265 | 0.204 | Potassium channel (Voltage-sensitive) activator | 0.106 0.046 DBMET02244 0.106 0.046 DBMET02247 0.204 0.005 DBMET02248 0.089 0.07 DBMET02249 0.118 0.034 DBMET02251 | DBMET02248 | |
| 0.019 | 0.247 | 0.126 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.126 0.007 DBMET02245 0.063 0.027 DBMET02248 | DBMET02245 | |
| 0.002 | 0.231 | 0.016 | G-protein-coupled receptor 120 agonist | 0.016 0.013 DBMET02251 | DBMET02251 | |
| 0.049 | 0.279 | 0.121 | Neurotrophic factor | 0.115 0.104 DBMET02248 0.121 0.093 DBMET02251 | DBMET02251 | |
| 0.02 | 0.251 | 0.148 | Glutamate decarboxylase inhibitor | 0.131 0.017 DBMET02245 0.087 0.038 DBMET02248 0.088 0.037 DBMET02250 0.148 0.013 DBMET02251 | DBMET02251 | |
| 0.03 | 0.261 | 0.177 | Glutamate dehydrogenase inhibitor | 0.091 0.036 DBMET02245 0.087 0.039 DBMET02248 0.073 0.052 DBMET02250 0.177 0.012 DBMET02251 | DBMET02251 | |
| 0.021 | 0.252 | 0.05 | Angiotensin-converting enzyme inhibitor | 0.05 0.047 DBMET02250 | DBMET02250 | |
| 0.005 | 0.236 | 0.057 | Cholecystokinin antagonist | 0.057 0.021 DBMET02251 | DBMET02251 | |
| 0.008 | 0.24 | 0.038 | Nicotinic acid receptor 2 agonist | 0.038 0.022 DBMET02248 0.035 0.026 DBMET02251 | DBMET02248 | |
| 0.013 | 0.245 | 0.055 | Acetylcholine M5 receptor antagonist | 0.055 0.051 DBMET02244 0.055 0.051 DBMET02247 | DBMET02247 | |
| 0.009 | 0.241 | 0.019 | Toll-Like receptor 8 agonist | 0.019 0.018 DBMET02248 | DBMET02248 | |
| 0.133 | 0.365 | 0.334 | 5 Hydroxytryptamine uptake stimulant | 0.278 0.058 DBMET02245 0.248 0.083 DBMET02244 0.248 0.083 DBMET02247 0.225 0.11 DBMET02248 0.215 0.125 DBMET02250 0.256 0.075 DBMET02255 0.334 0.031 DBMET02251 | DBMET02251 | |
| 0.008 | 0.241 | 0.023 | Factor XIII inhibitor | 0.023 0.01 DBMET02244 0.023 0.01 DBMET02247 | DBMET02247 | |
| 0.01 | 0.243 | 0.046 | Metalloproteinase-3 inhibitor | 0.046 0.038 DBMET02245 | DBMET02245 | |
| 0.02 | 0.254 | 0.13 | Carbonic anhydrase stimulant | 0.064 0.036 DBMET02244 0.064 0.036 DBMET02247 0.064 0.036 DBMET02248 0.13 0.013 DBMET02251 | DBMET02251 | |
| 0.066 | 0.301 | 0.132 | Platelet adhesion inhibitor | 0.132 0.128 DBMET02250 | DBMET02250 | |
| 0.013 | 0.249 | 0.068 | Acetylcholine M5 receptor agonist | 0.061 0.054 DBMET02245 0.068 0.046 DBMET02244 0.068 0.046 DBMET02247 | DBMET02247 | |
| 0.033 | 0.27 | 0.076 | Peroxisome proliferator-activated receptor gamma antagonist | 0.066 0.064 DBMET02245 0.068 0.058 DBMET02250 0.076 0.041 DBMET02251 | DBMET02251 | |
| 0.062 | 0.3 | 0.252 | Antimitotic | 0.252 0.059 DBMET02245 | DBMET02245 | |
| 0.038 | 0.276 | 0.11 | Acetylcholine muscarinic antagonist | 0.11 0.078 DBMET02244 0.11 0.078 DBMET02247 | DBMET02247 | |
| 0.033 | 0.274 | 0.121 | Prolactin inhibitor | 0.088 0.069 DBMET02245 0.121 0.037 DBMET02251 | DBMET02251 | |
| 0.089 | 0.331 | 0.183 | Death-associated protein kinase 2 inhibitor | 0.183 0.05 DBMET02244 0.183 0.05 DBMET02247 0.179 0.055 DBMET02248 0.169 0.069 DBMET02255 0.179 0.055 DBMET02251 | DBMET02247 | |
| 0.013 | 0.255 | 0.042 | Glutamate (mGluR3) agonist | 0.034 0.017 DBMET02245 0.031 0.024 DBMET02248 0.042 0.008 DBMET02251 | DBMET02251 | |
| 0.012 | 0.254 | 0.039 | Retinoic acid alpha receptor agonist | 0.039 0.027 DBMET02248 | DBMET02248 | |
| 0.013 | 0.256 | 0.047 | Plasminogen activator inhibitor antagonist | 0.047 0.036 DBMET02250 | DBMET02250 | |
| 0.005 | 0.249 | 0.064 | 5-Alpha-reductase inhibitor | 0.064 0.015 DBMET02251 | DBMET02251 | |
| 0.045 | 0.289 | 0.107 | ABCA1 expression enhancer | 0.085 0.076 DBMET02248 0.107 0.042 DBMET02251 | DBMET02251 | |
| 0.034 | 0.279 | 0.511 | Ferrochelatase inhibitor | 0.25 0.013 DBMET02244 0.25 0.013 DBMET02247 0.309 0.007 DBMET02248 0.113 0.058 DBMET02249 0.126 0.05 DBMET02255 0.511 0.002 DBMET02251 | DBMET02251 | |
| 0.018 | 0.262 | 0.16 | Sphingosine 1-phosphate receptor 4 agonist | 0.16 0.007 DBMET02245 0.097 0.027 DBMET02248 0.128 0.014 DBMET02251 | DBMET02245 | |
| 0.007 | 0.252 | 0.038 | DNA gyrase subunit B inhibitor | 0.038 0.027 DBMET02251 | DBMET02251 | |
| 0.036 | 0.281 | 0.109 | Protein kinase C gamma inhibitor | 0.109 0.064 DBMET02245 0.094 0.088 DBMET02248 | DBMET02245 | |
| 0.026 | 0.271 | 0.102 | Glucosylceramidase inhibitor | 0.06 0.031 DBMET02245 0.102 0.008 DBMET02248 | DBMET02248 | |
| 0.074 | 0.32 | 0.14 | CF transmembrane conductance regulator agonist | 0.14 0.096 DBMET02245 0.138 0.1 DBMET02248 0.133 0.11 DBMET02255 0.136 0.105 DBMET02251 | DBMET02245 | |
| 0.004 | 0.25 | 0.016 | Free fatty acid receptor 1 agonist | 0.016 0.014 DBMET02251 | DBMET02251 | |
| 0.014 | 0.26 | 0.17 | Phosphofructokinase-1 inhibitor | 0.17 0.015 DBMET02245 0.097 0.033 DBMET02248 0.091 0.036 DBMET02250 0.14 0.02 DBMET02251 | DBMET02245 | |
| 0.095 | 0.343 | 0.161 | Cyclin-dependent kinase 3 inhibitor | 0.161 0.075 DBMET02245 | DBMET02245 | |
| 0.031 | 0.28 | 0.084 | Caspase 7 inhibitor | 0.084 0.052 DBMET02248 0.079 0.063 DBMET02251 | DBMET02248 | |
| 0.01 | 0.26 | 0.062 | Integrin alpha5beta1 antagonist | 0.062 0.011 DBMET02251 | DBMET02251 | |
| 0.025 | 0.277 | 0.074 | CD45 antagonist | 0.074 0.014 DBMET02251 | DBMET02251 | |
| 0.009 | 0.263 | 0.1 | NMDA 2C receptor antagonist | 0.081 0.024 DBMET02244 0.081 0.024 DBMET02247 0.073 0.03 DBMET02248 0.065 0.039 DBMET02255 0.1 0.016 DBMET02251 | DBMET02251 | |
| 0.012 | 0.266 | 0.046 | Dihydrofolate reductase inhibitor | 0.046 0.025 DBMET02251 | DBMET02251 | |
| 0.044 | 0.3 | 0.161 | Aryl hydrocarbon receptor agonist | 0.161 0.127 DBMET02248 0.159 0.129 DBMET02251 | DBMET02248 | |
| 0.034 | 0.29 | 0.114 | Anabolic | 0.105 0.055 DBMET02245 0.097 0.066 DBMET02248 0.114 0.046 DBMET02251 | DBMET02251 | |
| 0.05 | 0.306 | 0.163 | TRPA1 agonist | 0.12 0.058 DBMET02248 0.163 0.023 DBMET02251 | DBMET02251 | |
| 0.017 | 0.274 | 0.048 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.034 DBMET02245 0.044 0.023 DBMET02248 0.048 0.017 DBMET02251 | DBMET02251 | |
| 0.01 | 0.268 | 0.218 | Aldose reductase inhibitor | 0.218 0.006 DBMET02250 | DBMET02250 | |
| 0.048 | 0.306 | 0.168 | Interleukin 1 antagonist | 0.168 0.048 DBMET02245 | DBMET02245 | |
| 0.004 | 0.263 | 0.04 | Integrin alpha4 antagonist | 0.04 0.013 DBMET02251 | DBMET02251 | |
| 0.09 | 0.35 | 0.28 | DNA synthesis inhibitor | 0.28 0.051 DBMET02245 0.189 0.14 DBMET02244 0.189 0.14 DBMET02247 0.23 0.083 DBMET02248 0.198 0.126 DBMET02249 0.193 0.133 DBMET02250 0.224 0.089 DBMET02255 0.235 0.078 DBMET02251 | DBMET02245 | |
| 0.07 | 0.329 | 0.192 | Tumour necrosis factor antagonist | 0.192 0.058 DBMET02245 | DBMET02245 | |
| 0.029 | 0.29 | 0.189 | Aminopeptidase B inhibitor | 0.12 0.053 DBMET02245 0.147 0.039 DBMET02248 0.189 0.024 DBMET02251 | DBMET02251 | |
| 0.007 | 0.27 | 0.025 | Retinoid X gamma receptor antagonist | 0.025 0.024 DBMET02251 | DBMET02251 | |
| 0.004 | 0.268 | 0.036 | Cholecystokinin A antagonist | 0.036 0.027 DBMET02251 | DBMET02251 | |
| 0.018 | 0.283 | 0.066 | Sphingosine kinase 2 inhibitor | 0.066 0.025 DBMET02245 | DBMET02245 | |
| 0.004 | 0.27 | 0.028 | Kynurenine 3 monooxygenase inhibitor | 0.024 0.021 DBMET02250 0.028 0.017 DBMET02251 | DBMET02251 | |
| 0.015 | 0.28 | 0.054 | Adenylate cyclase 1 inhibitor | 0.054 0.022 DBMET02248 | DBMET02248 | |
| 0.024 | 0.291 | 0.088 | Glutamate (mGluR7) antagonist | 0.077 0.031 DBMET02245 0.088 0.019 DBMET02251 | DBMET02251 | |
| 0.053 | 0.32 | 0.212 | Arachidonic acid antagonist | 0.212 0.022 DBMET02245 0.181 0.052 DBMET02248 0.16 0.077 DBMET02250 0.189 0.044 DBMET02251 | DBMET02245 | |
| 0.003 | 0.271 | 0.054 | VLA-4 antagonist | 0.054 0.012 DBMET02251 | DBMET02251 | |
| 0.039 | 0.306 | 0.193 | Protein-tyrosine phosphatase inhibitor | 0.193 0.049 DBMET02251 | DBMET02251 | |
| 0.007 | 0.276 | 0.035 | Epoxide hydrolase 1 inhibitor | 0.035 0.016 DBMET02244 0.035 0.016 DBMET02247 0.035 0.016 DBMET02251 | DBMET02251 | |
| 0.007 | 0.276 | 0.08 | NMDA 2 receptor antagonist | 0.077 0.046 DBMET02244 0.077 0.046 DBMET02247 0.08 0.044 DBMET02255 | DBMET02255 | |
| 0.016 | 0.286 | 0.103 | Na+ K+ transporting ATPase inhibitor | 0.103 0.029 DBMET02245 0.068 0.062 DBMET02248 | DBMET02245 | |
| 0.009 | 0.281 | 0.063 | 5 Hydroxytryptamine agonist | 0.063 0.052 DBMET02244 0.063 0.052 DBMET02247 | DBMET02247 | |
| 0.015 | 0.286 | 0.144 | Nicotinic alpha4beta2 receptor antagonist | 0.144 0.009 DBMET02244 0.144 0.009 DBMET02247 0.09 0.04 DBMET02255 | DBMET02247 | |
| 0.019 | 0.292 | 0.072 | Toll-Like receptor 7 antagonist | 0.072 0.044 DBMET02244 0.072 0.044 DBMET02247 | DBMET02247 | |
| 0.036 | 0.31 | 0.148 | GABA C receptor rho-1 antagonist | 0.132 0.031 DBMET02245 0.094 0.072 DBMET02244 0.094 0.072 DBMET02247 0.117 0.042 DBMET02248 0.088 0.082 DBMET02250 0.148 0.022 DBMET02251 | DBMET02251 | |
| 0.011 | 0.287 | 0.143 | NMDA receptor glycine site agonist | 0.112 0.011 DBMET02248 0.143 0.005 DBMET02251 | DBMET02251 | |
| 0.022 | 0.298 | 0.117 | Cathepsin G inhibitor | 0.117 0.028 DBMET02251 | DBMET02251 | |
| 0.03 | 0.308 | 0.079 | Exportin-1 inhibitor | 0.079 0.027 DBMET02245 | DBMET02245 | |
| 0.032 | 0.311 | 0.096 | Aminoacyl-tRNA synthetase inhibitor | 0.096 0.05 DBMET02245 | DBMET02245 | |
| 0.004 | 0.283 | 0.039 | Thyroid hormone alpha antagonist | 0.039 0.004 DBMET02251 | DBMET02251 | |
| 0.078 | 0.357 | 0.136 | Death-associated protein kinase 1 inhibitor | 0.136 0.066 DBMET02244 0.136 0.066 DBMET02247 0.119 0.116 DBMET02255 | DBMET02247 | |
| 0.019 | 0.299 | 0.12 | Protein-tyrosine phosphatase 1B inhibitor | 0.12 0.063 DBMET02251 | DBMET02251 | |
| 0.041 | 0.321 | 0.124 | Interleukin 5 antagonist | 0.124 0.021 DBMET02245 0.084 0.065 DBMET02248 | DBMET02245 | |
| 0.063 | 0.345 | 0.184 | Prostaglandin dehydrogenase inhibitor | 0.184 0.169 DBMET02248 | DBMET02248 | |
| 0.004 | 0.289 | 0.055 | GP IIb/IIIa receptor antagonist | 0.055 0.03 DBMET02251 | DBMET02251 | |
| 0.005 | 0.291 | 0.036 | Integrin alphaVbeta3 antagonist | 0.036 0.006 DBMET02251 | DBMET02251 | |
| 0.016 | 0.304 | 0.045 | Glutamate (mGluR8) antagonist | 0.045 0.012 DBMET02251 | DBMET02251 | |
| 0.031 | 0.32 | 0.126 | Glutamate (mGluR6) antagonist | 0.069 0.041 DBMET02245 0.09 0.016 DBMET02248 0.126 0.005 DBMET02251 | DBMET02251 | |
| 0.043 | 0.333 | 0.176 | Angiogenesis stimulant | 0.176 0.107 DBMET02245 0.175 0.108 DBMET02248 0.176 0.107 DBMET02251 | DBMET02251 | |
| 0.021 | 0.312 | 0.062 | Nicotinic alpha3beta2 receptor antagonist | 0.062 0.024 DBMET02244 0.062 0.024 DBMET02247 | DBMET02247 | |
| 0.05 | 0.341 | 0.121 | Farnesoid X receptor antagonist | 0.121 0.102 DBMET02248 | DBMET02248 | |
| 0.004 | 0.296 | 0.039 | Vitronectin receptor antagonist | 0.039 0.008 DBMET02251 | DBMET02251 | |
| 0.003 | 0.297 | 0.02 | Thromboxane A2 agonist | 0.015 0.011 DBMET02248 0.02 0.005 DBMET02251 | DBMET02251 | |
| 0.043 | 0.337 | 0.15 | Cytokine production inhibitor | 0.15 0.062 DBMET02245 | DBMET02245 | |
| 0.011 | 0.306 | 0.045 | Nicotinic receptor alpha3 subunit antagonist | 0.045 0.03 DBMET02244 0.045 0.03 DBMET02247 | DBMET02247 | |
| 0.131 | 0.427 | 0.198 | MAP kinase kinase 3 inhibitor | 0.198 0.129 DBMET02244 0.198 0.129 DBMET02247 | DBMET02247 | |
| 0.001 | 0.298 | 0.018 | Thyroid hormone beta agonist | 0.018 0.004 DBMET02251 | DBMET02251 | |
| 0.058 | 0.356 | 0.164 | GABA C receptor rho-2 antagonist | 0.164 0.057 DBMET02245 0.13 0.105 DBMET02244 0.13 0.105 DBMET02247 0.147 0.077 DBMET02248 0.152 0.07 DBMET02251 | DBMET02245 | |
| 0.043 | 0.342 | 0.411 | Aldehyde dehydrogenase inhibitor | 0.411 0.005 DBMET02245 0.134 0.058 DBMET02248 0.108 0.086 DBMET02250 0.119 0.072 DBMET02251 | DBMET02245 | |
| 0.006 | 0.305 | 0.026 | Integrin alphaVbeta1 antagonist | 0.026 0.008 DBMET02251 | DBMET02251 | |
| 0.019 | 0.319 | 0.076 | Sirtuin 1 inhibitor | 0.076 0.038 DBMET02251 | DBMET02251 | |
| 0.008 | 0.31 | 0.046 | NMDA 2A receptor antagonist | 0.046 0.042 DBMET02251 | DBMET02251 | |
| 0.011 | 0.314 | 0.064 | 5 Hydroxytryptamine 1B antagonist | 0.064 0.046 DBMET02244 0.064 0.046 DBMET02247 | DBMET02247 | |
| 0.018 | 0.322 | 0.052 | Glutamate (mGluR group III) antagonist | 0.042 0.034 DBMET02250 0.052 0.019 DBMET02251 | DBMET02251 | |
| 0.046 | 0.35 | 0.095 | Hematopoietic | 0.079 0.078 DBMET02248 0.095 0.042 DBMET02251 | DBMET02251 | |
| 0.036 | 0.342 | 0.086 | MAP kinase kinase 7 inhibitor | 0.077 0.054 DBMET02245 0.075 0.062 DBMET02244 0.075 0.062 DBMET02247 0.086 0.032 DBMET02248 0.081 0.044 DBMET02255 | DBMET02248 | |
| 0.022 | 0.328 | 0.081 | Purinergic P2X1 antagonist | 0.058 0.046 DBMET02245 0.081 0.024 DBMET02251 | DBMET02251 | |
| 0.042 | 0.351 | 0.16 | Photosensitizer | 0.125 0.051 DBMET02245 0.132 0.044 DBMET02248 0.16 0.026 DBMET02251 | DBMET02251 | |
| 0.037 | 0.348 | 0.07 | MDM2 inhibitor | 0.07 0.038 DBMET02245 0.067 0.048 DBMET02251 | DBMET02245 | |
| 0.02 | 0.331 | 0.088 | Alpha 1L adrenoreceptor agonist | 0.047 0.021 DBMET02254 0.052 0.015 DBMET02244 0.052 0.015 DBMET02247 0.088 0.004 DBMET02255 | DBMET02255 | |
| 0.016 | 0.328 | 0.068 | CDC25A inhibitor | 0.068 0.061 DBMET02251 | DBMET02251 | |
| 0.041 | 0.354 | 0.107 | NADPH oxidase inhibitor | 0.107 0.102 DBMET02255 | DBMET02255 | |
| 0.008 | 0.321 | 0.159 | Prostaglandin antagonist | 0.159 0.009 DBMET02250 0.082 0.022 DBMET02251 | DBMET02250 | |
| 0.004 | 0.317 | 0.045 | Retinoid X receptor agonist | 0.045 0.02 DBMET02251 | DBMET02251 | |
| 0.044 | 0.358 | 0.158 | MAP3K9 inhibitor | 0.127 0.099 DBMET02245 0.158 0.049 DBMET02248 | DBMET02248 | |
| 0.007 | 0.321 | 0.034 | ATP citrate lysase inhibitor | 0.034 0.019 DBMET02251 | DBMET02251 | |
| 0.006 | 0.32 | 0.014 | Integrin beta6 antagonist | 0.014 0.009 DBMET02251 | DBMET02251 | |
| 0.004 | 0.319 | 0.042 | Free fatty acid receptor 1 antagonist | 0.042 0.014 DBMET02251 | DBMET02251 | |
| 0.014 | 0.332 | 0.073 | Protein kinase C beta inhibitor | 0.073 0.042 DBMET02244 0.073 0.042 DBMET02247 0.065 0.059 DBMET02255 | DBMET02247 | |
| 0.006 | 0.324 | 0.07 | Ornithine carbamoyltransferase inhibitor | 0.055 0.035 DBMET02245 0.07 0.025 DBMET02248 0.065 0.028 DBMET02251 | DBMET02248 | |
| 0.016 | 0.336 | 0.07 | Epoxide hydrolase inhibitor | 0.07 0.053 DBMET02251 | DBMET02251 | |
| 0.007 | 0.329 | 0.041 | Dopamine D5 agonist | 0.041 0.027 DBMET02255 | DBMET02255 | |
| 0.014 | 0.337 | 0.067 | Glutamate (mGluR8) agonist | 0.036 0.032 DBMET02245 0.039 0.024 DBMET02248 0.067 0.005 DBMET02251 | DBMET02251 | |
| 0.024 | 0.348 | 0.095 | Ornithine decarboxylase inhibitor | 0.095 0.05 DBMET02245 0.091 0.055 DBMET02251 | DBMET02245 | |
| 0.017 | 0.342 | 0.058 | Glutamate (mGluR4) antagonist | 0.058 0.015 DBMET02251 | DBMET02251 | |
| 0.018 | 0.347 | 0.093 | Phospholipase D inhibitor | 0.093 0.02 DBMET02244 0.093 0.02 DBMET02247 0.074 0.046 DBMET02251 | DBMET02247 | |
| 0.007 | 0.337 | 0.058 | Thyroid hormone agonist | 0.033 0.01 DBMET02248 0.058 0.004 DBMET02251 | DBMET02251 | |
| 0.004 | 0.335 | 0.023 | Imidazoline I1 receptor antagonist | 0.023 0.012 DBMET02244 0.023 0.012 DBMET02247 | DBMET02247 | |
| 0.056 | 0.388 | 0.321 | Non-steroidal antiinflammatory agent | 0.321 0.024 DBMET02245 0.179 0.088 DBMET02250 0.165 0.099 DBMET02251 | DBMET02245 | |
| 0.001 | 0.333 | 0.015 | Glutamate (mGluR6) agonist | 0.015 0.006 DBMET02251 | DBMET02251 | |
| 0.012 | 0.345 | 0.12 | Phosphodiesterase IV inhibitor | 0.12 0.033 DBMET02245 | DBMET02245 | |
| 0.004 | 0.338 | 0.066 | Ribonucleoside-diphosphate reductase inhibitor | 0.066 0.031 DBMET02251 | DBMET02251 | |
| 0.006 | 0.34 | 0.024 | Retinoid X beta receptor antagonist | 0.024 0.008 DBMET02251 | DBMET02251 | |
| 0.028 | 0.363 | 0.119 | AMP-activated protein kinase stimulant | 0.119 0.05 DBMET02245 | DBMET02245 | |
| 0.022 | 0.357 | 0.094 | Histamine N-methyltransferase inhibitor | 0.094 0.051 DBMET02244 0.094 0.051 DBMET02247 | DBMET02247 | |
| 0.001 | 0.336 | 0.008 | Integrin alpha5beta6 antagonist | 0.008 0.004 DBMET02251 | DBMET02251 | |
| 0.029 | 0.365 | 0.106 | Alkaline phosphatase inhibitor | 0.106 0.105 DBMET02248 | DBMET02248 | |
| 0.004 | 0.341 | 0.067 | Ribonucleotide reductase inhibitor | 0.067 0.033 DBMET02251 | DBMET02251 | |
| 0.03 | 0.368 | 0.103 | Acetylcholine antagonist | 0.103 0.089 DBMET02244 0.103 0.089 DBMET02247 | DBMET02247 | |
| 0.01 | 0.348 | 0.068 | Dihydroorotase inhibitor | 0.066 0.013 DBMET02248 0.068 0.012 DBMET02251 | DBMET02251 | |
| 0.031 | 0.368 | 0.104 | Cholinergic antagonist | 0.104 0.091 DBMET02244 0.104 0.091 DBMET02247 | DBMET02247 | |
| 0.055 | 0.393 | 0.131 | NOS3 expression enhancer | 0.131 0.097 DBMET02251 | DBMET02251 | |
| 0.012 | 0.35 | 0.083 | Alpha adrenoreceptor agonist | 0.083 0.036 DBMET02244 0.083 0.036 DBMET02247 0.067 0.048 DBMET02255 | DBMET02247 | |
| 0.009 | 0.35 | 0.044 | Nerve growth factor antagonist | 0.044 0.028 DBMET02244 0.044 0.028 DBMET02247 | DBMET02247 | |
| 0.033 | 0.378 | 0.17 | Pyruvate kinase inhibitor | 0.17 0.1 DBMET02251 | DBMET02251 | |
| 0.005 | 0.351 | 0.126 | Integrin antagonist | 0.126 0.013 DBMET02251 | DBMET02251 | |
| 0.059 | 0.406 | 0.234 | Lipoxygenase inhibitor | 0.184 0.158 DBMET02245 0.234 0.111 DBMET02251 | DBMET02251 | |
| 0.008 | 0.358 | 0.043 | Glutamate (mGluR1) agonist | 0.03 0.01 DBMET02248 0.043 0.005 DBMET02251 | DBMET02251 | |
| 0.085 | 0.435 | 0.429 | Toll-Like receptor 7 agonist | 0.429 0.05 DBMET02250 | DBMET02250 | |
| 0.006 | 0.357 | 0.043 | Retinoid X alpha receptor agonist | 0.043 0.018 DBMET02251 | DBMET02251 | |
| 0.069 | 0.42 | 0.191 | Lipocortins synthesis antagonist | 0.191 0.062 DBMET02251 | DBMET02251 | |
| 0.032 | 0.387 | 0.14 | Cathepsin H inhibitor | 0.112 0.086 DBMET02245 0.114 0.083 DBMET02248 0.14 0.054 DBMET02251 | DBMET02251 | |
| 0.083 | 0.438 | 0.427 | Toll-Like receptor agonist | 0.427 0.05 DBMET02250 | DBMET02250 | |
| 0.105 | 0.463 | 0.541 | Cyclophilin D inhibitor | 0.484 0.055 DBMET02245 0.541 0.039 DBMET02250 0.29 0.172 DBMET02251 | DBMET02250 | |
| 0.03 | 0.388 | 0.106 | Bile acid receptor antagonist | 0.096 0.059 DBMET02248 0.106 0.038 DBMET02251 | DBMET02251 | |
| 0.049 | 0.408 | 0.115 | Folate antagonist | 0.115 0.044 DBMET02251 | DBMET02251 | |
| 0.031 | 0.394 | 0.084 | Vanilloid 4 agonist | 0.072 0.058 DBMET02248 0.084 0.034 DBMET02251 | DBMET02251 | |
| 0.006 | 0.37 | 0.074 | Nicotinic acid receptor agonist | 0.074 0.008 DBMET02248 0.069 0.009 DBMET02251 | DBMET02248 | |
| 0.012 | 0.376 | 0.36 | Porphobilinogen synthase inhibitor | 0.128 0.026 DBMET02248 0.094 0.039 DBMET02255 0.36 0.004 DBMET02251 | DBMET02251 | |
| 0.014 | 0.378 | 0.053 | Kainate receptor agonist | 0.053 0.011 DBMET02251 | DBMET02251 | |
| 0.006 | 0.375 | 0.092 | NMDA receptor subunit 3B antagonist | 0.044 0.031 DBMET02248 0.092 0.012 DBMET02251 | DBMET02251 | |
| 0.011 | 0.381 | 0.042 | Retinoid X alpha receptor antagonist | 0.042 0.012 DBMET02251 | DBMET02251 | |
| 0.019 | 0.391 | 0.084 | Macrophage migration inhibitory factor inhibitor | 0.084 0.046 DBMET02245 0.075 0.057 DBMET02250 | DBMET02245 | |
| 0.023 | 0.395 | 0.079 | Neuropeptide Y antagonist | 0.079 0.059 DBMET02244 0.079 0.059 DBMET02247 | DBMET02247 | |
| 0.001 | 0.373 | 0.018 | Aminopeptidase A inhibitor | 0.018 0.013 DBMET02251 | DBMET02251 | |
| 0.012 | 0.385 | 0.105 | DNA gyrase inhibitor | 0.105 0.017 DBMET02251 | DBMET02251 | |
| 0.004 | 0.378 | 0.042 | Fructose-1,6-bisphosphatase inhibitor | 0.04 0.039 DBMET02248 0.042 0.036 DBMET02251 | DBMET02251 | |
| 0.029 | 0.405 | 0.084 | Thioredoxin inhibitor | 0.084 0.073 DBMET02251 | DBMET02251 | |
| 0.012 | 0.389 | 0.049 | Retinoid X receptor antagonist | 0.049 0.013 DBMET02251 | DBMET02251 | |
| 0.017 | 0.395 | 0.063 | Aryl hydrocarbon receptor antagonist | 0.063 0.048 DBMET02245 | DBMET02245 | |
| 0.001 | 0.38 | 0.023 | Carbonic anhydrase XI inhibitor | 0.023 0.004 DBMET02251 | DBMET02251 | |
| 0.002 | 0.381 | 0.014 | CXC chemokine 4 receptor agonist | 0.014 0.012 DBMET02244 0.014 0.012 DBMET02247 | DBMET02247 | |
| 0.004 | 0.385 | 0.028 | Lysine carboxypeptidase inhibitor | 0.028 0.018 DBMET02251 | DBMET02251 | |
| 0.033 | 0.418 | 0.112 | Adenylate cyclase inhibitor | 0.112 0.074 DBMET02251 | DBMET02251 | |
| 0.016 | 0.402 | 0.128 | Alcohol dehydrogenase inhibitor | 0.128 0.03 DBMET02245 0.093 0.06 DBMET02248 0.109 0.044 DBMET02250 0.109 0.043 DBMET02251 | DBMET02245 | |
| 0.031 | 0.423 | 0.082 | mTOR complex 2 inhibitor | 0.082 0.064 DBMET02245 | DBMET02245 | |
| 0.002 | 0.395 | 0.037 | Arginase inhibitor | 0.037 0.025 DBMET02251 | DBMET02251 | |
| 0.01 | 0.408 | 0.035 | Tryptophan 5 hydroxylase inhibitor | 0.035 0.026 DBMET02251 | DBMET02251 | |
| 0.004 | 0.403 | 0.073 | NMDA receptor subunit 3A antagonist | 0.073 0.013 DBMET02251 | DBMET02251 | |
| 0.005 | 0.404 | 0.046 | Thromboxane A2 antagonist | 0.046 0.04 DBMET02251 | DBMET02251 | |
| 0.009 | 0.41 | 0.058 | Membrane dipeptidase inhibitor | 0.042 0.024 DBMET02248 0.058 0.011 DBMET02251 | DBMET02251 | |
| 0.065 | 0.467 | 0.187 | MAP kinase kinase 4 inhibitor | 0.187 0.02 DBMET02245 | DBMET02245 | |
| 0.007 | 0.409 | 0.055 | Dihydroorotate dehydrogenase inhibitor | 0.055 0.032 DBMET02248 0.052 0.035 DBMET02251 | DBMET02248 | |
| 0.014 | 0.417 | 0.198 | NMDA receptor agonist | 0.104 0.018 DBMET02248 0.198 0.005 DBMET02251 | DBMET02251 | |
| 0.01 | 0.415 | 0.053 | Thromboxane synthase inhibitor | 0.051 0.045 DBMET02250 0.053 0.042 DBMET02251 | DBMET02251 | |
| 0.052 | 0.461 | 0.144 | Focal adhesion kinase 2 inhibitor | 0.144 0.141 DBMET02244 0.144 0.141 DBMET02247 | DBMET02247 | |
| 0.044 | 0.455 | 0.137 | Pregnane X receptor agonist | 0.129 0.103 DBMET02244 0.129 0.103 DBMET02247 0.137 0.081 DBMET02248 0.128 0.105 DBMET02251 | DBMET02248 | |
| 0.005 | 0.418 | 0.049 | Toll-Like receptor 8 antagonist | 0.049 0.042 DBMET02244 0.049 0.042 DBMET02247 | DBMET02247 | |
| 0.006 | 0.422 | 0.048 | Thromboxane antagonist | 0.048 0.044 DBMET02251 | DBMET02251 | |
| 0.017 | 0.438 | 0.21 | Potassium channel activator | 0.21 0.008 DBMET02248 0.131 0.027 DBMET02251 | DBMET02248 | |
| 0.016 | 0.437 | 0.114 | Glycine receptor antagonist | 0.077 0.061 DBMET02244 0.077 0.061 DBMET02247 0.084 0.05 DBMET02248 0.114 0.021 DBMET02251 | DBMET02251 | |
| 0.019 | 0.445 | 0.15 | GABA C receptor antagonist | 0.12 0.052 DBMET02245 0.124 0.049 DBMET02248 0.15 0.03 DBMET02251 | DBMET02251 | |
| 0.078 | 0.505 | 0.384 | GABA C receptor rho-3 antagonist | 0.232 0.171 DBMET02245 0.374 0.073 DBMET02244 0.374 0.073 DBMET02247 0.353 0.084 DBMET02248 0.303 0.114 DBMET02255 0.384 0.069 DBMET02251 | DBMET02251 | |
| 0.014 | 0.442 | 0.063 | Botulinum neurotoxin type A inhibitor | 0.054 0.047 DBMET02248 0.063 0.034 DBMET02251 | DBMET02251 | |
| 0.011 | 0.439 | 0.062 | Myc inhibitor | 0.051 0.044 DBMET02244 0.051 0.044 DBMET02247 0.062 0.027 DBMET02248 0.049 0.046 DBMET02251 | DBMET02248 | |
| 0.003 | 0.432 | 0.071 | Glutamate (mGluR1a) agonist | 0.037 0.006 DBMET02248 0.071 0.004 DBMET02251 | DBMET02251 | |
| 0.002 | 0.432 | 0.052 | NMDA receptor glycine site antagonist | 0.052 0.005 DBMET02251 | DBMET02251 | |
| 0.026 | 0.457 | 0.098 | Beta amyloid protein antagonist | 0.098 0.092 DBMET02245 | DBMET02245 | |
| 0.074 | 0.507 | 0.235 | Analgesic | 0.235 0.197 DBMET02244 0.235 0.197 DBMET02247 | DBMET02247 | |
| 0.003 | 0.439 | 0.079 | Prostaglandin D2 antagonist | 0.079 0.005 DBMET02250 | DBMET02250 | |
| 0.002 | 0.443 | 0.026 | Nicotinic acid receptor 1 antagonist | 0.022 0.008 DBMET02248 0.026 0.005 DBMET02251 | DBMET02251 | |
| 0.011 | 0.455 | 0.143 | RET inhibitor | 0.143 0.065 DBMET02255 | DBMET02255 | |
| 0.024 | 0.469 | 0.091 | Xanthine oxidase inhibitor | 0.091 0.07 DBMET02245 | DBMET02245 | |
| 0.018 | 0.463 | 0.1 | Potassium channel (Ca-activated) activator | 0.099 0.056 DBMET02248 0.1 0.055 DBMET02251 | DBMET02251 | |
| 0.005 | 0.455 | 0.043 | Glutamate (mGluR3) antagonist | 0.043 0.018 DBMET02251 | DBMET02251 | |
| 0.023 | 0.473 | 0.143 | HIV-1 integrase (Overall Integration) inhibitor | 0.087 0.069 DBMET02245 0.097 0.057 DBMET02248 0.143 0.028 DBMET02251 | DBMET02251 | |
| 0.028 | 0.49 | 0.122 | DOPA decarboxylase inhibitor | 0.109 0.059 DBMET02245 0.101 0.073 DBMET02248 0.122 0.042 DBMET02251 | DBMET02251 | |
| 0.018 | 0.482 | 0.391 | GABA C receptor agonist | 0.105 0.062 DBMET02245 0.112 0.055 DBMET02244 0.112 0.055 DBMET02247 0.148 0.035 DBMET02248 0.094 0.073 DBMET02255 0.391 0.005 DBMET02251 | DBMET02251 | |
| 0.01 | 0.477 | 0.067 | AICAR transformylase inhibitor | 0.067 0.011 DBMET02251 | DBMET02251 | |
| 0.067 | 0.541 | 0.206 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.206 0.15 DBMET02244 0.206 0.15 DBMET02247 | DBMET02247 | |
| 0.006 | 0.482 | 0.125 | Argininosuccinate synthase inhibitor | 0.125 0.014 DBMET02251 | DBMET02251 | |
| 0.034 | 0.51 | 0.177 | Histone deacetylase SIRT1 inhibitor | 0.177 0.042 DBMET02251 | DBMET02251 | |
| 0.007 | 0.485 | 0.076 | Alpha 2 adrenoreceptor agonist | 0.076 0.026 DBMET02244 0.076 0.026 DBMET02247 | DBMET02247 | |
| 0.038 | 0.519 | 0.116 | Transcription factor STAT6 inhibitor | 0.116 0.068 DBMET02244 0.116 0.068 DBMET02247 0.111 0.078 DBMET02255 | DBMET02247 | |
| 0.005 | 0.488 | 0.091 | Prostaglandin-E synthase inhibitor | 0.091 0.032 DBMET02251 | DBMET02251 | |
| 0.007 | 0.493 | 0.04 | Integrin alpha2 antagonist | 0.04 0.021 DBMET02251 | DBMET02251 | |
| 0.003 | 0.49 | 0.036 | Nicotinic acid receptor 2 antagonist | 0.032 0.011 DBMET02248 0.036 0.007 DBMET02251 | DBMET02251 | |
| 0.024 | 0.514 | 0.132 | Interleukin 8 antagonist | 0.118 0.064 DBMET02248 0.132 0.048 DBMET02251 | DBMET02251 | |
| 0.022 | 0.514 | 0.142 | Anticoagulant | 0.142 0.088 DBMET02251 | DBMET02251 | |
| 0.003 | 0.498 | 0.044 | Kainate receptor 2 antagonist | 0.044 0.019 DBMET02251 | DBMET02251 | |
| 0.016 | 0.514 | 0.043 | Integrin alpha1beta1 antagonist | 0.043 0.014 DBMET02251 | DBMET02251 | |
| 0.005 | 0.508 | 0.046 | Nicotinic receptor alpha4 subunit antagonist | 0.046 0.041 DBMET02244 0.046 0.041 DBMET02247 | DBMET02247 | |
| 0.01 | 0.516 | 0.049 | Glutamate (mGluR group III) agonist | 0.049 0.024 DBMET02251 | DBMET02251 | |
| 0.031 | 0.54 | 0.139 | Thiol protease inhibitor | 0.139 0.081 DBMET02248 0.129 0.098 DBMET02251 | DBMET02248 | |
| 0.014 | 0.523 | 0.064 | Histone deacetylase SIRT3 inhibitor | 0.064 0.038 DBMET02244 0.064 0.038 DBMET02247 | DBMET02247 | |
| 0.013 | 0.524 | 0.078 | 5 Hydroxytryptamine 3 agonist | 0.078 0.029 DBMET02244 0.078 0.029 DBMET02247 | DBMET02247 | |
| 0.017 | 0.529 | 0.18 | 5 Hydroxytryptamine 3A agonist | 0.18 0.022 DBMET02244 0.18 0.022 DBMET02247 0.108 0.067 DBMET02255 | DBMET02247 | |
| 0.011 | 0.523 | 0.044 | Purinergic P2X4 antagonist | 0.044 0.036 DBMET02244 0.044 0.036 DBMET02247 | DBMET02247 | |
| 0.018 | 0.532 | 0.118 | Thrombolytic | 0.117 0.114 DBMET02250 0.118 0.112 DBMET02251 | DBMET02251 | |
| 0.107 | 0.621 | 0.199 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.199 0.169 DBMET02244 0.199 0.169 DBMET02247 | DBMET02247 | |
| 0.003 | 0.52 | 0.026 | Glucagon receptor antagonist | 0.026 0.025 DBMET02251 | DBMET02251 | |
| 0.008 | 0.527 | 0.076 | Diacylglycerol O-acyltransferase inhibitor | 0.046 0.042 DBMET02248 0.076 0.016 DBMET02251 | DBMET02251 | |
| 0.006 | 0.526 | 0.072 | 5 Hydroxytryptamine 3A antagonist | 0.072 0.039 DBMET02244 0.072 0.039 DBMET02247 | DBMET02247 | |
| 0.003 | 0.526 | 0.046 | Kainate receptor antagonist | 0.046 0.024 DBMET02251 | DBMET02251 | |
| 0.005 | 0.531 | 0.037 | Oxytocin agonist | 0.037 0.035 DBMET02248 | DBMET02248 | |
| 0.004 | 0.534 | 0.08 | Cannabinoid CB1 receptor agonist | 0.08 0.028 DBMET02248 | DBMET02248 | |
| 0.006 | 0.547 | 0.035 | Glutamate (mGluR4) agonist | 0.035 0.022 DBMET02251 | DBMET02251 | |
| 0.013 | 0.558 | 0.086 | Protein kinase C mu inhibitor | 0.086 0.073 DBMET02244 0.086 0.073 DBMET02247 | DBMET02247 | |
| 0.005 | 0.554 | 0.031 | Carboxypeptidase B inhibitor | 0.031 0.026 DBMET02251 | DBMET02251 | |
| 0.005 | 0.554 | 0.049 | Histamine agonist | 0.049 0.042 DBMET02244 0.049 0.042 DBMET02247 | DBMET02247 | |
| 0.041 | 0.594 | 0.238 | Antibacterial | 0.238 0.188 DBMET02245 0.216 0.211 DBMET02251 | DBMET02245 | |
| 0.006 | 0.561 | 0.091 | Acetylcholine nicotinic agonist | 0.091 0.044 DBMET02244 0.091 0.044 DBMET02247 | DBMET02247 | |
| 0.003 | 0.566 | 0.045 | Antimetabolite | 0.045 0.036 DBMET02251 | DBMET02251 | |
| 0.004 | 0.577 | 0.054 | Nicotinic neuronal receptor agonist | 0.054 0.041 DBMET02244 0.054 0.041 DBMET02247 | DBMET02247 | |
| 0.016 | 0.589 | 0.135 | Histone deacetylase class III inhibitor | 0.135 0.057 DBMET02251 | DBMET02251 | |
| 0.006 | 0.622 | 0.062 | Histone deacetylase inhibitor | 0.062 0.05 DBMET02248 | DBMET02248 | |
| 0.017 | 0.635 | 0.126 | Cyclin-dependent kinase 8 inhibitor | 0.126 0.108 DBMET02248 | DBMET02248 | |
| 0.004 | 0.628 | 0.062 | 5 Hydroxytryptamine 2C agonist | 0.062 0.02 DBMET02244 0.062 0.02 DBMET02247 | DBMET02247 | |
| 0.003 | 0.632 | 0.04 | Angiotensin AT1 receptor antagonist | 0.04 0.033 DBMET02251 | DBMET02251 | |
| 0.035 | 0.675 | 0.239 | Immunomodulator | 0.239 0.124 DBMET02248 0.208 0.154 DBMET02251 | DBMET02248 | |
| 0.003 | 0.657 | 0.06 | Thymidylate synthase inhibitor | 0.06 0.017 DBMET02251 | DBMET02251 | |
| 0.002 | 0.702 | 0.028 | AMPA 3 receptor antagonist | 0.028 0.022 DBMET02251 | DBMET02251 | |
| 0.004 | 0.712 | 0.044 | AMPA 4 receptor antagonist | 0.044 0.021 DBMET02251 | DBMET02251 | |
| 0.034 | 0.749 | 0.349 | Antiinflammatory | 0.349 0.173 DBMET02245 | DBMET02245 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |